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Antibiotic resistance poses a significant threat to human health. The lagging 
development of new antibiotics and the rapid exchange of resistance genes have created 
a need for alternative methods to combat emerging ‘superbugs’. One promising strategy 
involves using lytic phages – bacterial viruses that lyse and kill their hosts, releasing 
their progeny. Modification-dependent restriction (MDR) systems are innate bacterial 
defense systems that recognize and degrade phage DNA, thus preventing mature phage 
production. MDR systems are highly conserved in antibiotic resistant bacteria and 
several phage-encoded inhibitors have been identified. Understanding the molecular 
mechanisms of these systems can therefore provide a means to increase the therapeutic 
potential of phages.  
McrBC is a two-component MDR system that restricts DNA containing 4-, 5-, 
or 5-hydroxy-methyl cytosines. The first component, McrB, contains an N-terminal 
domain that recognizes and binds the modified site and a C-terminal AAA+ motor 
domain that hydrolyzes GTP and mediates nucleotide-dependent oligomerization. 
Bioinformatics coupled with a structure of the Escherichia coli McrB suggest that McrB 
homologs may target different nucleic acids using different molecular mechanisms. To 
assess the species-specific determinants of McrB DNA-binding, I have purified the 
 putative DNA binding domains of different McrB homologs and determined their 
atomic resolution structures by x-ray crystallography.  
The structures of the Thermococcus gammatolerans (Tg) and Staphylothermus 
marinus McrB N-terminal domains were solved to 1.68 Å and 2.10 Å respectively and 
revealed structural homology to the PUA-like domains of RNA binding proteins. The 
structures identified a conserved aromatic cage required for RNA binding via base-
flipping of a modified adenosine base. A structure of the TgMcrB in complex with DNA 
containing 5-methylcytosine confirms this base-flipping mechanism and provides a 
model for how these proteins bind modified nucleic acids. Furthermore, the structure of 
the Helicobactor pylori (Hp) LlaJI N-terminal domain was solved to 1.97 Å and 
revealed structural homology to the B3 family of site-specific DNA binding proteins. 
LlaJI is a homolog of McrB and functions as a restriction modification (R/M) system 
that targets DNA site specifically. Together these structures underscore the inherent 
structural plasticity of McrB DNA binding and provides insights into their molecular 
mechanisms of target specificity. 
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Chapter 1. Introduction 
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In 1915, Frederick Twort unsuccessfully attempted to propagate vaccinia virus. Instead, 
he observed ‘transparent’ plaques on his plates, which upon closer examination, turned 
out to be zones of dead bacteria. Twort proposed three possible hypotheses to his 
observation: 1) it could be a novel manifestation of the bacterial life cycle, 2) an 
unknown protein or enzyme could be produced by the bacteria itself, or 3) it could be 
some sort of “ultra-microscopic virus” that infects bacteria (Keen et al., 2015). At the 
time, Twort’s hypotheses could not be confirmed nor rejected. It wasn’t until two years 
later that Felix d’Herelle published similar observations and attributed them to a new 
type of virus that infected bacteria which he later dubbed the bacteriophage (phage). 
Over the next century, phages would play a leading role in numerous biological 
advancements including discovery of DNA as the genetic material and how it is encoded 
as a triplet (codons). 
By 1919, d’Herelle had speculated that phages were responsible for the recovery 
of a variety of illnesses that he proposed to employ laboratory-produced phage as both 
prophylactic and therapeutic agents against bacterial infection. The idea was to exploit 
the ability of phage to serve as ‘bacterial-killers’ and stave off infection. Due to its 
narrow specificity of cellular target hosts, phage therapy was initially only used to treat 
acute and chronic infections. Indeed, the only uses for phage therapy in the 1920 – 1930s 
was serum therapy against pathogens such as pneumococci and diphtheria (Wittebole et 
al., 2014). Unfortunately, skepticism and controversy surrounded phage therapy from 
the beginning due to early studies lacking appropriate controls and producing 
inconsistent results. Moreover, the emergence of penicillin as a ‘broad spectrum’ 
antibiotic in 1942 further dampened any interest in phage research and therapy 
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(Summers et al., 2012). However, over the last decade, the emergence of multi-drug 
resistant bacteria has led researchers to reconsider phage therapy as a viable alternative 
to antibiotics.  
 Phage virions are remarkably diverse and vary widely in size, shape, and 
complexity. Their genomes are even more diverse ranging in size from 3.4 kb to <500 
kb and encode all the necessary components to successfully propagate the phage through 
its host. All phages can undergo the lytic cycle while only temperate phages exhibit 
bimodality and can form stable lysogens. The lytic state is a productive phase leading 
up to the synthesis of new phage particles. In the lytic cycle, the host cell machinery 
expresses phage genes, replicates the phage genome, and manufactures more phage 
particles to eventually rupture (lyse) the host, thereby killing the host and completing 
its reproductive cycle. The lysogenic state, however, is a dormant, or ‘silent’, phase 
where the viral genome is integrated within the host chromosome as a prophage. A 
complex regulatory network, best characterized in  phage, regulates lytic gene 
inhibition and activation as a binary switch to convert it from the lysogenic state to the 
lytic state (Oppenheim et al., 2005).  
The inherent nature of the lytic cycle leading to host cell death resulted in phages 
playing a significant role in driving bacterial evolution. Bacteria pose several layers of 
defense against phage infection, ranging from preventing phage adsorption to a wide 
arsenal of restriction systems poised to target and degrade the invading genetic material. 
The first layer of defense, preventing phage adsorption, is primarily extracellular and 
can be divided into three categories: blocking phage receptors, producing a complex 
extracellular matrix that can act as a physical barrier between phage and their receptors, 
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or the production of competitive inhibitors against phage receptors. The second layer of 
defense resides intercellularly and involves the use of restriction enzymes (REases), or 
enzymes designed to target and cleave phage (and other foreign) nucleic acids (Labrie 
et al., 2010). Phage has in turn adapted chemical modifications to their genetic material 
to circumvent these systems. This development has resulted in an ongoing evolutionary 
arms race between bacteria and phage with bacteria evolving novel systems to target 
and degrade the adapted phage genome. Meanwhile, phage escape these systems by 
 
 
Figure 1. Overview of bacterial defense and phage exclusion systems. Restriction modification 
systems target DNA site specifically and include Types I, II, and III. Modification-dependent 
Restriction Systems target DNA modification specifically and include restriction enzymes like Mrr, 
McrBC, and GmrS/GmrD. Phage exclusion systems are bacterial suicide systems induced by phage 
encoded proteins and include examples like RexA, the Lit protease, and the prrC anticodon 
nuclease. CRISPR-Cas is a bacterial adaptive immune system that stores foreign DNA within the 
genome as a ‘memory’ to selectively target the same DNA in future infections. 
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incorporating different sequences, modifications, and in some cases, phage encoded 
inhibitors to their genome. Figure 1 briefly illustrates several mechanisms of bacterial 
defense systems including restriction modification (RM), modification dependent 
restriction (MDR), phage exclusion, and CRISPR-Cas systems. Each of these will be 
discussed in detail below. 
 
RESTRICTION MODIFICATION SYSTEMS 
Classical RM systems are site specific restriction systems that target and cleave (phage) 
DNA sequence specifically. The operons containing RM systems ubiquitously encode 
for an associated methyltransferase (MTase) designed to methylate the target site within 
the host genome to protect it from self-cleavage. Three classes of RM systems have 
been identified, Type I, II, and III, and vary in their structural composition, target 
recognition, and mechanism of restriction. Type I REases are large, heteropentameric 
proteins with separate restriction (R), methylation (M), and sequence recognition (S) 
subunits encoded by the host specificity determinant (hsd) genes, hsdR, hsdM, and hsdS 
respectively. The cleavage competent type I system is composed of R2M2S subunits and 
requires ATP, Mg2+, and S-adenosylmethionine (SAM) for REase and MTase activity 
(Loenen et al., 2014). These systems exhibit bipartite DNA recognition through the S 
subunit with each assembly spaced as far as 2 kilobases (kb) apart. The R subunit is 
essential for REase activity, consisting of an N-terminal endonuclease fused to a C-
terminal, RecA-like ATP-dependent motor domain (Iyer et al., 2004). ATP-dependent 
DNA translocation of type I REases has been observed to generate DNA loops visible 
by electron microscopy (EM) (Rosamond et al., 1979; Yuan et al., 1980) and atomic 
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force microscopy (AFM) (van Noort et al., 2004; Neaves et al., 2009). DNA is cleaved 
through the R subunits once translocation is blocked, either by collision with another 
molecule or by the presence of supercoiled DNA (Loenen et al., 2014). Examples of 
Type I RM systems include the Escherichia coli (E. coli) EcoKI and EcoBI.  
 Unlike type I RM systems, type II are enormously useful REases in the 
enzymatic toolboxes of molecular biologists. Type II REases are smaller, homodimeric 
proteins consisting of R2 subunits capable of target recognition and cleavage 
accompanied by a separate M subunit for methylase activity. Alternative fused forms of 
R and M (R∼M) have been observed and can form homodimeric (R∼M)2 complexes. 
These systems target short, symmetric (palindromic) sequences site-specifically and can 
readily cleave DNA in the absence of ATP. The first type II REase discovered was 
Haemophilus influenza, serotype d (HindIII, AAGCTT) by Hamilton Smith and Daniel 
Nathans which was awarded the Nobel Prize in Physiology or Medicine in 1978. This 
discovery spurred a growing interest in restriction enzymes eventually resulting in the 
discovery of two of the best characterized type II REases, EcoRI (GAATTC) and 
EcoRV (GATATC). Crystal structures of EcoRI and EcoRV in complex with their 
cognate DNA sequence yielded significant insight into the biomolecular mechanism of 
DNA recognition and cleavage. The first of these, EcoRI, was reported in 1986 and was 
crystallized with self-complementary 12- and 13-mer oligos in the absence of Mg2+ to 
avoid DNA cleavage (McClarin et al., 1986). The second, EcoRV, was reported seven 
years later in both a DNA-bound and unbound state, also in the absence of Mg2+ 
(Winkler et al., 1993). These two structures allowed for several key generalizations to 
be made about type II REases: 
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1. They form symmetric homodimers (2R) that are coincident with their palindromic 
recognition sequence (Figures 2A and 2C). The recognition and cleavage machinery 
from both subunits are oriented equally around each half-site in the palindromic 
sequence. 
2. The substrate DNA is bound in a high energy conformation (underwound in EcoRI 
and kinked in EcoRV). This distortion is part of the recognition process and is 
coupled to conformational changes in the protein. 
3. They both contain a central, four-stranded -sheet flanked by two -helices on both 
sides (forming an  topology). This core fold was subsequently found (with 
variations) in almost all Type II REases whose structures have been determined. It 
 
Figure 2. Structural comparison of EcoRI and EcoRV bound to their cognate DNA sequences. 
A. Cartoon representation of EcoRI in complex with DNA containing its cognate GAATTC 
sequence showin in 2 orientations. B. Zoomed in view of the EcoRI DNA binding and cleavage 
sites. D91, E111, and K113 form the conserved PD-(DE)XK motif. The remaining residues are 
involved in site-specific recognition. C. Cartoon representation of EcoRV in complex with DNA 
containing its cognate GATATC sequence showin in 2 orientations. D. Zoomed in view of the 
EcoRV DNA binding and cleavage sites. D74, D90, and K92 form the conserved PD-(DE)XK 
motif. The remaining residues are involved in site-specific recognition. 
 8 
is characterized in the SCOP (structural characterization of proteins) database as the 
‘REase-like fold’. 
4. Site-specific DNA recognition is achieved by a redundant network of extensive 
contacts in the major groove (Figures 2B and 2D). This ensures that contacts to the 
base pairs are over-determined, thereby increasing reliability.  
5. The catalytic site consists of two acidic residues and one basic residue, falling under 
the canonical PD-(D/E)XK family of endonucleases (Figures 2B and 2D). Previous 
bioinformatic analysis indicated that among 289 Type II REases, 69% belonged to 
the PD-(D/E)XK phosphodiesterase superfamily (Orlowski et al., 2008).  
Most of these residues in EcoRI and EcoRV were probed by site-directed mutagenesis 
experiments which have confirmed their importance in DNA binding or cleavage. Since 
then, over 30 additional Type II REase – DNA complexes have been solved at 
increasingly higher resolution and provide only a snapshot of the dynamic process of 
DNA cleavage by these enzymes. 
 Although the generalizations to Type II REases by structural data like EcoRI 
and EcoRV are largely consistent across the family, as more enzymes are discovered, 
more marked differences among them became apparent. Even amongst enzymes with 
comparable activities, little similarity was found at the amino acid sequence level. This 
diversity came as a surprise to many investigators in the field, and to date, there is still 
no consensus on what it means evolutionarily. Thus, characterizing Type II variants by 
the conventional genotype grouping was impractical. Instead, Type II REases were 
grouped by phenotype based on their behavior and cleavage properties, a scheme 
proposed by Roberts over a decade ago (Roberts et al., 2003). EcoRI, EcoRV, and most 
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of the familiar laboratory cloning enzymes belong to the Type IIP subtype because they 
recognize palindromic DNA sequences. Additional subtypes include Type IIL, a unique 
R∼M REase that cleaves and methylates in one bi-functional active site (e.g. MmeI) 
(Callahan et al., 2016) and Type IIM, which includes REases capable of cleaving 
modified DNA (e.g. DpnI and MspJI) (Siwek et al., 2012; Horton et al., 2014). Although 
many other Type II variants exist, there are far too many to describe each in detail.  
Type III RM systems are perhaps the least well-characterized with only ~140 
confirmed and putative types discovered. These systems also comprise of separate R 
and M subunits forming homodimeric M2 and heterotetrameric R2M2 complexes. The 
M subunit in M2 or R2M2 is responsible for DNA methylation while the R subunit is 
responsible for ATP hydrolysis, DNA translocation, and cleavage (Raghavendra et al., 
2012). They are like Type I systems as they require ATP-dependent translocation for 
long-distance DNA cleavage, however, differ in that they require two inversely oriented 
recognition sites that can vary in their spatial orientation. (Meisel et al., 1992). Examples 
of Type III RM systems include the E. coli EcoP1I and EcoP15I.  
 
 
Figure 3. Domain architecture of McrBC. Top. Domain architecture of EcMcrB illustrating the 
N-terminal putative DNA binding domain and C-terminal AAA+ domain. Bottom. Domain 
architecture of EcMcrC illustrating the N-terminal DUF and C-terminal canonical PD-(D/E)XK 
endonuclease. 
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MODIFICATION DEPENDENT RESTRICTION SYSTEMS 
Regardless of their structural and biochemical differences, all Type I – III RM 
(excluding Type IIM) systems share at least one key feature: they target DNA site-
specifically and are protected against by site-specific modification. Biological DNA 
modifications have been known for many years to play critical roles in all domains of 
life, including eukaryotes, prokaryotes, and bacteriophages. In eukaryotes, the 
modification N6-methyladenine (m6A) has been shown as a major cancer cell marker 
and its abundance is directly linked to tumorigenesis (Xiao et al., 2018) while 5-
methylcytosine (m5C) modifications in CpG islands plays a major regulatory role in 
transcriptional gene activation and silencing (Handy et al., 2011). Like eukaryotes, 
bacteria also make widespread use of post-replicative DNA methylation for epigenetic 
regulation. However, instead of cytosine methylation, bacteria primarily make use of 
adenine methylation. Furthermore, bacteria and their predatory bacteriophage also have 
the added benefit of DNA modifications to protect their genetic material from RM 
systems. These modifications are the quintessential driver in the evolutionary arms race 
between bacteria and phage and led to the development of MDR systems to protect the 
host against the modified phage genomes. 
Modification-dependent restriction was first observed in 1952 with T4 phage 
that contained hydroxymethylcytosine (hm5C)-substituted DNA and marks the 
discovery of the first restriction system by Luria and Human (Luria and Human, 1952). 
The original observation led to the discovery of modifying enzymes that glucosylate 
hm5C in T-even phages and of genes encoding enzymes that restrict non-glucosylated 
phage DNA: rglA and rglB (restricts glucoseless phage). These genes were later 
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renamed to mcrA and mcrBC (modified cytosine restriction) and formed the new class 
of MDR systems, or Type IV systems, that recognize and cleave modified DNA. Unlike 
classical RM systems that contain an associated MTase to block cleavage, operons 
encoding for MDR systems only include genes for site recognition and restriction. McrA 
and McrBC are prototypical members and target DNA containing 4-methylcytosine 
(m4C), m5C, and hm5C. Together, McrA and McrBC form the E. coli immigration 
control system for modified DNA. A third E. coli enzyme, mrr (modified DNA 
rejection and restriction), targets DNA containing either methylcytosine or 
methyladenine. Since their discovery, additional key MDR systems have been identified 
including PvuRts1I, MspJI (from Type IIM), and GmrSD. 
 McrA was originally identified in E. coli K-12 (EcoK12) as a REase that 
restricted non-glucosylated, hm5C-containing T-even phages, a group of dsDNA 
bacteriophages from Myoviridae that infect E. coli. It was subsequently demonstrated 
to restrict m5C modified DNA in a Mn2+ and sequence dependent manner. For instance, 
McrA has been shown to be very effective in restricting DNA that has been methylated 
by M.HpaII (Cm5CGG) but not by other methyltransferases (Raleigh et al., 1986). 
Electrophoretic mobility shift assays (EMSAs) suggest that the true specificity is 
Ym5CGR where Y is any pyrmidine (T or C) and R is any purine (A or G) (Mulligan et 
al., 2010). A recent crystal structure in the absence of DNA revealed that EcoK12 McrA 
dimerizes through its C-terminal HNH endonuclease domain whereas its N-terminal 
domain contains a putative modification-dependent binding domain (Czapinska et al., 
2018). The overall domain organization is reminiscent of the two-domain organization 
of the SRA-HNH endonuclease previously characterized where DNA binding is 
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achieved through base-flipping in the SRA domain (Han et al., 2015). However, 
fluorescent studies suggest EcoK12 McrA does not bind modified DNA via base-
flipping as originally believed (Czapinska et al., 2018).  
The McrBC restriction system is the second half of the E. coli immigration 
control system and contains the mcrB and mcrC genes that encode for McrB and McrC 
respectively. McrB consists of an N-terminal putative DNA binding domain (McrB-N) 
and a C-terminal GTP-dependent AAA+ (ATPases associated with various cellular 
activities) motor domain (McrB AAA+) (Figure 3). A cryptic translational start site in 
mcrB encodes for a shorter version of McrB including only the motor domain and is 
thought to play a regulatory role in inhibiting McrBC activity (Dila et al., 1990). McrC 
consists of an N-terminal domain of unknown function (DUF), presumably for GTPase 
stimulation, and a C-terminal canonical PD-(D/E)XK endonuclease domain. DNA 
binding occurs through McrB-N and has been shown to recognize DNA containing m4C, 
 
 
Figure 4. Crystal structure of EcMcrB bound to m5C DNA. A. Cartoon representation of 
EcMcrB (orange) bound to m5C-DNA (light blue) shown in two, perpendicular orientations. B. 
Zoomed in view of the flipped out m5C base stabilized within McrB. The resulting gap is stabilized 
by insertion of Y41. 
 13 
m5C, or hm5C in RmC sites (Krüger et al., 1995). A crystal structure of the E. coli McrB-
N (EcMcrB-N) in complex with m5C DNA reveals that recognition is achieved via base-
flipping of the m5C out of the DNA duplex (Figure 4A) (Sukackaite et al., 2012). The 
m5C base is stabilized within McrB through several polar (Y64, I82 – T85) and 
hydrophobic/aromatic (L68 and Y117) contacts (Figure 4B). The resulting gap in the 
DNA duplex is then stabilized by insertion of the Y41 residue (Figure 4B). Mutagenesis 
of Y41 abolishes EcMcrB-N DNA binding in vitro (Sukackaite et al., 2012). 
Furthermore, phylogenetic analysis of McrB homologs indicate that McrB-N is highly 
divergent among both bacteria and archaea. Together, these data suggest that homologs 
of EcMcrB-N may utilize alternate modes of substrate recognition or bind different 
targets.  
Unlike McrB-N, McrB AAA+ is highly conserved. Like other AAA+ proteins, 
McrB can also undergo nucleotide specific oligomerization. Estimated molecular 
weights of both McrB or McrB AAA+ in complex with GTPS by SEC suggests it 
oligomerizes as a heptamer (Panne et al., 2001). Preliminary scanning transmission 
electron microscopy (STEM) also supports this stoichiometry (Panne et al., 2001). 
McrC can only interact with oligomeric McrB with a stoichiometry of 5:1 or 7:2 of B:C 
as evidenced by SEC and STEM (Panne et al, 2001). Furthermore, previous binding and 
kinetic studies show that, 1) McrB binds GTP with an affinity of 10-6 M-1, 2) McrB 
binds GDP >50-fold and ATP >1000-fold weaker than GTP, 3) McrB hydrolyzes GTP 
with a steady-state rate of ~0.5 min-1, and 4) McrC stimulates GTP hydrolysis ~30-fold 
independent of DNA (Pieper et al., 1997). In fact, no difference in GTP binding or 
kinetics have been observed between McrB and McrB AAA+ suggesting that GTP 
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hydrolysis is mutually exclusive from DNA binding. Unfortunately, the structural and 
biochemical underpinnings of GTP binding, hydrolysis, and GTPase stimulation in 
McrBC remains elusive. Future studies are required to tease apart how this unique 
AAA+ domain can use GTP as its substrate.  
Previous genetic characterization of the mcrBC locus revealed highly conserved 
sequences within McrB AAA+ predicted to be the GTP-binding motif: GxxxxGK 
(position 201-208), DxxG (position 300-303), and NxxD (333-336) (Dila et al., 1990). 
To better understand the subtleties underlying the cryptic nature of the McrBs AAA+ 
GTP specificity, a structural comparison between ATPases and GTPases must first be 
drawn. GTPases contain five key motifs, G1-G5, and are all involved in nucleotide 
binding. Ras is a canonical example and used to illustrate the five motifs (Figure 5) 
(Scheffzek et al., 1997). The G1 motif forms the P-loop with the consensus sequence 
 
 
Figure 5. The five conserved GTPase motifs of Ras. Cartoon representation of the small GTPase 
Ras. The five key GTPase motifs, P-Loop (purple), Switch I (red), Switch II (green), G4 (cyan), and 
G5 (yellow) are colored accordingly. The bound GDP-AlF3 is shown in sticks and colored wheat. 
The Mg2+ cofactor and catalytic water are shown in spheres. 
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GxxxxGKS/T. A conserved Thr in G2 and a direct or water-mediated contact by a 
conserved Asp in G3 participate in Mg2+ binding. An additional conserved Gln in G3 
positions the catalytic water. Both G2 and G3 undergo -phosphate-dependent 
conformational changes and have been renamed switch I and switch II accordingly.  The 
G4 motif contains the consensus N/TKXD where the Asp mediates specific binding to 
 
 
Figure 6. Structural comparison of the Ras-RasGAP and Gi1-RGS4 complexes. A. Cartoon 
representation of Ras (white) in complex to its GAP, RasGAP (orange). B. Zoomed in view of the 
active site of Ras-RasGAP. The arrow points to the catalytic Arg Finger (orange) from RasGAP 
oriented in trans. C. Cartoon representation of Giα1 (white) in complex to its GAP, RGS4 (orange). 
D. Zoomed in view of the active site of Giα1-RGS4. The arrow points to the catalytic Arg Finger 
(red) from Giα1 oriented in cis. All key structural elements are color coordinated and labeled 
accordingly. 
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the guanine base. Mutation of this Asp to Asn confers specificity to XTP. The G5 motif 
is not entirely well conserved and works to provide additional stabilizing interactions to 
the guanine base and/or ribose (Daumke et al., 2016).  
Two additional proteins are generally required to regulate the GTPase cycle: 1) 
a GTPase activating protein (GAP) to stimulate GTPase activity and 2) a guanine 
nucleotide exchange factor (GEF) to facilitate exchange of GDP to GTP. A catalytic 
Arg residue (Arg finger) is also required for stimulated GTP hydrolysis and stabilizes 
the charge in the transition state. The crystal structures of many G-proteins coupled to 
their respective GAPs have been solved and define several canonical mechanisms for 
GTPase stimulation. In Ras-RasGAP, the Arg finger resides within the GAP and its 
association to the GTPase drives stimulation (Figure 6A-B) (Scheffzek et al., 1997). 
Alternatively, in Gi1-RGS4, the Arg finger is intrinsic to Gi1 and association to its 
GAP correctly positions the switch regions to drive stimulation (Figure 6C-D) (Tesmer 
et al., 1997). Other modes of stimulation have also been observed independent of a GAP 
as found in the dynamin family of GTPases which achieve GTPase stimulation by 
 
 
Figure 7. Crystal structure of the DnaA dimer. A. Cartoon representation of the DnaA dimer. 
The subunit bound to AMPPCP is colored white and the subunit providing the Arg finger in trans is 
colored orange. B. Zoomed in view of the active site of the DnaA dimer. The five key ATPase 
motifs, Walker A (purple), Sensor I (red), Walker B (green), Sensor II (yellow), and Arg finger 
(orange) are colored accordingly. 
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homodimerization (Chappie et al., 2010).  
AAA+ proteins stem from the ASCE (additional strand conserved E) family of 
proteins as part of the C-terminal bundle classification (as opposed to the RecA-like 
ATPases from the C-terminal hairpin classification). Within the AAA+ superfamily is 
a subcategory of different “clades”, defined by different insertions of secondary 
structural elements within the core fold. For example, McrB resides within the H2-insert 
clade which is defined by a unique -hairpin insertion in helix 2. Like their GTPase 
counterparts, AAA+ proteins also contain several key structural motifs (Erzberger et al., 
2006). DnaA is a canonical example and used to illustrate these motifs (Figure 7A-B) 
(Erzberger et al., 2006). Walker A forms the P-loop with the consensus sequence 
GxPGxxKS/T (G1). Walker B contains a conserved DE motif to coordinate Mg2+ 
binding (switch I). Sensor I contains a conserved Asn used to position the catalytic water 
(switch II). Sensor II contains a conserved GAD and is involved in adenine base/ribose 
binding (G5) (Erzberger et al., 2006). Sensor II often contains an Arg that form 
stabilizing interactions with the  and  phosphates as seen in DnaA (Figure 7B) 
(Erzberger et al., 2006). AAA+ proteins also utilize an Arg finger for charge 
compensation that is usually provided via dimerization with another AAA+ protomer; 
dimerization forms composite active sites as illustrated in DnaA (Figure 7B). 
Organization of AAA+ oligomers typically form hexameric rings as seen with the 
minichromosome maintenance protein complex (MCM helicase) or helical filaments as 
seen with DnaA.  
Structurally, McrB is proposed to be a member of the AAA+ family. However, 
two of the three GTP-binding motifs initially proposed by Dila et al. were validated by 
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mutational analysis (Pieper et al., 1997 and 2002). The third motif, NTAD (NxxD, 
position 333-336), replaces sensor I in the AAA+ fold. The N333A mutant has no 
detectable DNA cleavage activity and severely diminished GTP binding and hydrolysis 
compared to the wild-type protein (Pieper et al., 1997). Homology of NTAD to the 
canonical G4 element (N/TKxD) of GTPases also led investigators to study the ability 
of D to N mutants to bind GTP. Interestingly, D336N mutants did not exhibit any DNA 
cleavage activity with GTP or XTP, and in fact, did not confer XTP specificity as seen 
in other GTPases. Furthermore, D336N mutants could still hydrolyze GTP despite being 
unable to be stimulated by McrC (~30% of wild-type activity) and explaining its 
inability to cleave DNA (Pieper et al., 1999). These results were almost paradoxical and 
left researchers questioning whether the conserved NTAD sequence was involved in 
guanine base binding or GTP hydrolysis, two independent events that usually require 
two motifs (G4 and switch I respectively) to accomplish.  
The GAP-like ability of McrC to stimulate McrBs GTPase activity has been less 
extensively studied. Two possible mechanisms of stimulation have been proposed: 1) 
McrC contains a key catalytic residue that upon binding the McrB oligomer, is 
positioned in trans (like Ras-RasGAP) or 2) McrC binding stabilizes flexible ‘switch’ 
regions in McrB orienting the catalytic machinery in cis (like Gia1-RGS4). Few attempts 
have been made to probe this hypothesis with mutational analysis, and those that have 
been attempted remain inconclusive. Unfortunately, in the absence of an atomic 
resolution structure, the biochemical means of GTP binding, hydrolysis, and GTPase 
stimulation in McrBC remains elusive.  
The ability of McrBC to restrict DNA, however, has been well-characterized 
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biochemically and strongly resembles 
the Type I RM systems. A mutational 
analysis of the PD-(D/E)XK motif 
suggests D244, D257, and K259 from 
the catalytic center of E. coli McrC 
(Pieper et al., 2002). Successful 
double-strand cleavage by EcMcrBC 
requires that two RmC sites 
(Sutherland et al., 1992; Krüger et al., 
1995) be separated by 30-3000 bp 
(Sutherland et al., 1992; Stewart et al., 
1998; Pieper et al., 2002). These sites 
can exist on either strand (Sutherland 
et al., 1992; Stewart et al., 2000) with 
an ideal cleavage length of ~40-60 bp 
(Pieper et al., 2002). They may also 
exist on different daughter strands 
across a replication fork (Ishikawa et 
al., 2011). Cleavage only occurs ~30-
35 bp from one of the two modified 
bases unless a translocation block is encountered (Panne et al., 1999). Long range (>80 
bp) cleavage requires GTPase hydrolysis and stimulation (Stewart et al., 1998). 
Monomeric or oligomeric McrB can associate with each site independent of McrC 
 
Figure 8. Proposed model for McrBC GTP-
stimulated hydrolysis and cleavage. The six steps 
involved in successful cleavage are numbered 
accordingly. 
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(Panne et al., 2001; Pieper et al., 2002).  
Over the past 3 decades, the combined efforts of many investigators attempting 
to understand the GTP-stimulated hydrolysis and cleavage by McrBC has yielded a 
working model for DNA restriction (Figure 8): 
1. McrB binds two RmC sites separated by 30-3000 bp 
2. McrB undergoes GTP-dependent oligomerization 
3. The McrB oligomer recruits McrC 
4. McrC stimulates McrBs GTPase activity 
5. Stimulation of GTP hydrolysis leads to DNA translocation 
6. Collision of two assemblies near one RmC site results in cleavage 
Although much of this model has been extensively supported by biochemistry, many 
questions remain: 
1. How do homologs of McrB bind DNA? 
2. How does McrB bind GTP? 
3. How does McrC bind and stimulate GTP hydrolysis? 
4. How does translocation occur? 
Further efforts must be taken to fully address these questions.  
One major complication in characterizing McrBC is its dependence on DNA 
modification. An McrBC related homolog, LlaJI, has been identified on pNP40, a 
naturally occurring 65 kb plasmid from Lactococcus lactis (L. lactis) (O'Driscoll et al., 
2004). The operon encoding LlaJI contains four proteins: two m5C methyltransferases, 
M1 and M2, and two restriction proteins, R1 and R2 (Figure 9A). LlaJI.R1 consists of 
an N-terminal putative DNA binding domain (LlaJI.R1 226) and a C-terminal AAA+ 
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(LlaJI.R1 226-585). LlaJI.R2 consists of an N-terminal DUF and a C-terminal PD-
(D/E)XK endonuclease. The McrB signature NTAD sequence is also conserved in 
LlaJI.R1 and suggests that LlaJI.R1 and R2 are McrB and C homologs respectively. The 
two methyltransferases, M1 and M2, have been shown to methylate the asymmetric 5’-
GACGC-3’ and complementary 5’-GCGTC-3’ respectively (O'Driscoll et al., 2005). A 
homolog of LlaJI in Clostridium cellulovorans (C.cellulovorans), Cce743, has also been 
identified with the same specificity (Yang et al., 2016). Both sequences exist within the 
LlaJI.R1 and R2 promoters and are transcriptionally regulated by methylation 
(O'Driscoll et al., 2005). Reconstitution of LlaJI.R1 in vitro confirms it recognizes the 
same asymmetric 5’-GACGC-3’ and 5’-GCGTC-3’ site-specifically as M1 and M2 and 
is blocked by methylation (O'Driscoll et al., 2006). Additionally, both LlaJI.R1 and R2 
are required for cleavage in vivo. The LlaJI restriction cassette therefore resembles 
classical Type IIS RM systems but may behave in a similar fashion as the Type IV 
MDR, McrBC.  
Another related RM system, LlaI, was identified on pTR2030, a 46.2 kb 
 
Figure 9. Organization of the Lactacoccus lactis LlaJI and LlaI operons. A. Organization of the 
LlaJI operon on the pNP40 plasmid in L. lactis. The operon encodes for four proteins: two m5C 
MTases, M1 and M2, and two Reases, R1 and R2. Percent identity and similarity of LlaJI.R1 and 
R2 to McrB and C are shown. B. Organization of the LlaI operon on the pTR2030 plasmid in L. 
lactis. The operon encodes for four proteins: one m5C MTase and three restriction proteins, 1-3.  
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conjugative plasmid from L. lactis. The operon encoding LlaI also contains four 
proteins: one methyltransferase, M, and three restriction proteins, 1-3 (Figure 9B) 
(O'Sullivan et al., 1995). Unlike McrBC and LlaJI, LlaI contains three restriction 
proteins: LlaI.1 is predicted to be a putative DNA binding domain, LlaI.2 is a AAA+ 
(with conserved NTAD), and LlaI.3 is a two domain protein with an N-terminal DUF 
and C-terminal PD-(D/E)XK endonuclease. In vivo studies show that LlaI.1 is essential 
for restriction while LlaI.2 and LlaI.3 allowed for inefficient restriction of phage DNA 
to occur (re O'Sullivan et al., 1995). A frameshift mutation in LlaI.M proved lethal to 
L. lactis implying that restriction is active without the M subunit and that methylation 
by LlaI.M protects the host from self-cleavage (O'Sullivan et al., 1995). A homolog of 
LlaI in Bacillus subtilis (B.subtilis), BsuMI, has also been identified as an isoschizomer 
to XhoI (CTCGAG) (Jentsch et al.. 1983). The operon encoding BsuMI resembles that 
of LlaI and includes four proteins with similar predicted functions. Together, the LlaJI, 
LlaI, and BsuMI systems provide a platform for studying McrBC-related mechanisms 
in a modification-independent manner. 
 The McrBC restriction system describes only one of the few MDR systems that 
have been identified. In fact, of these, very few have been biochemically characterized 
with even fewer high-resolution structures reported (including of the enigmatic Type 
IIM systems). Mechanisms of DNA methylation-dependent cleavage are therefore not 
very well understood as whole. In the past decade, several crystal structures have 
emerged that yield significant insight into both modification-specific DNA recognition 
and cleavage.  Of these are the Type IIM RM systems, DpnI and MspJI, and the Type 
IV MDR system, PvuRts1I. Although crystal structures are not yet available for the 
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Type IV MDR systems, Mrr and GmrSD, significant biochemical characterization on 
them has been made on and will also be discussed. 
The Mrr protein was first described in 1987 when expression of the site-specific 
adenine MTases, HhaII (Gm6ANTC) or PstI (CTGCm6AG), induced the RecA-
dependent SOS DNA repair response in E. coli by forming double-strand breaks (DSB) 
(Heitman et al., 1987). This result is similar to the expression of site-specific cytosine 
MTases in E. coli inducing the SOS response as a consequence of McrBC activity, 
suggesting that Mrr is an endonuclease that targets DNA containing m6A. Mrr was also 
discovered to be activated upon heterologous expression of foreign MTases, such as 
HhaII (Tesfazgi Mebrhatu M et al., 2011).  Interestingly, a recent study showed that a 
sub-lethal hydrostatic pressure (HP) shock of ~100 MPa also elicits the SOS response. 
In vivo fluorescence studies of GFP-Mrr not only revealed that 1) HP shock triggers Mrr 
activity by forcing inactive Mrr tetramers to dissociate into active dimers, but also that 
2) the HhaII MTase triggers Mrr activity by creating high affinity target sites on the 
chromosome, pulling the equilibrium from tetrameric to dimeric (Bourges et al., 2017). 
Together these data reveal a control mechanism for selective activation of Mrr driven 
through its oligomerization. To date, an atomic resolution structure of Mrr has not been 
solved, however, recent bioinformatic analyses supported by mutagenesis showed that 
it is composed of a winged helix (wH) and PD-(D/E)XK domains.   
The Type IIM REase, DpnI, is widely used as a tool in molecular biology for its 
ability to cleave modified DNA in a site-specific manner. It targets and cleaves the short, 
palindromic sequence G(m6A)TC and is 5-fold more efficient at cleaving fully-
methylated DNA than hemi-methylated (Siwek et al., 2012). The crystal structure of 
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DpnI bound to its cognate substrate was solved to 2.05 Å and revealed that DpnI, like 
Mrr, utilizes a winged helix (wH) domain to bind DNA (Figure 10A, green) (Siwek et 
al., 2012). The C-terminal, ‘recognition helix’, inserts directly into the major groove 
where the two m6A moieties are closest together (Figure 10B). An extensive network of 
hydrogen bonds is formed between the residues of the recognition helix and the purine 
bases within the recognition site. Unlike most RM or MDR systems that oligomerize to 
form a cleavage competent complex, DpnI has been shown to cleave DNA as a 
monomer. Interestingly, the conserved PD-(D/E)XK domain (Figure 10C) is located far 
 
 
Figure 10. Crystal structure of DpnI bound to m6A DNA. A. Cartoon representation of DpnI 
bound to m6A DNA. The winged helix domain (green), PD-(D/E)XK domain (pink), and m6A DNA 
(light blue) are colored accordingly. B. Zoomed in view of the DNA binding site. The m6A bases 
are colored yellow and shown in sticks. Residues important for DNA binding are colored green and 
shown in sticks. C. Zoomed in view of the PD-(D/E)XK active site. Residues important for DNA 
cleavage are colored pink and shown in sticks. 
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from the recognition site and suggests that DpnI must either undergo drastic 
conformational changes or cleave at a different site. Indeed, structural modeling shows 
that DpnI likely binds at one site and cleaves at another (Siwek et al., 2012).  
Like DpnI, MsPJI also belongs to the Type IIM family of REases and cleaves 
 
 
Figure 11. Crystal structure of MspJI bound to m5C DNA. A. Cartoon representation of MsPJI 
bound to m5C DNA. Both tetramers are shown bound to DNA molecule 1 (light blue) while only 
tetramer 2 is shown bound to both DNA molecules 1 and 2. (light blue and orange respectively). 
The four chains in tetramer 2 are colored differently for clarity. Only the yellow and pink subunits 
interact with DNA. B. Zoomed in view of the m5C binding pocket nonspecifically bound to a G 
base. Residues forming stabilizing contacts are shown in sticks and colored grey. C. Zoomed in 
view of the m5C binding pocket bound to m5C. Residues forming stabilizing contacts are shown in 
sticks and colored yellow. 
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modified DNA. It recognizes the m5CNNR or hm5CNNR (where N = any nucleotide 
and R = purine, A or G) and cleaves downstream ~9 bases away on the modified strand 
and ~13 bases away on the complementary strand, leaving a ~9/13 cleavage product 
with short 3’-overhangs (Cohen-Karni et al., 2011; Zheng et al., 2010). MspJI is 
reminiscent of the Type IIS family of REases which have a similar domain architecture 
and cleave outside of their recognition sequence. These REases often behave 
cooperatively and are catalyzed by two or more allosterically regulated molecules, 
typically due to the independently acting active sites. MspJI, for instance, is stimulated 
by the addition of oligonucleotides that contain its recognition sequence (Cohen-Karni 
et al., 2011; Zheng et al., 2010). A crystal structure of the MspJI apoprotein reveals that 
it forms a homotetramer where two molecules are close together (‘closed’ 
conformation) while two are farther apart (‘open’ conformation) and supports the idea 
of allostericity (Horton et al., 2012). This is further corroborated by the crystal structure 
of the m5C DNA bound complex where the homotetramer is shown to interact with two 
DNA molecules while each DNA molecule is bound to two homotetramers (Figure 11A) 
(Horton et al., 2014). Interestingly, only two molecules (yellow and pink) of the 
homotetramer ever engage the DNA in the ‘open’ conformation (Figure 11A). Each of 
these two molecules therefore forms two interactions, one with each of the two bound 
DNA duplexes. For instance, the yellow molecule directly interacts with the m5C base 
via its N-terminal domain on one DNA duplex while poising its C-terminal PD-
(D/E)XK domain towards the other duplex (Figure 11C). The other molecule, however, 
nonspecifically flips out the base 13 bp downstream in the complementary strand 
(Figure 11B). This base is only partially stabilized within the m5C binding pocket and 
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forms different interactions than the bound m5C (Figures 11B-C). Base-flipping of the 
m5C (and nonspecific) base is accomplished via an SRA (SET and RING-associated) 
domain which has been shown to bind m5C DNA via base-flipping previously 
(Hashimoto et al., 2008). The non-specific binding and concomitant base-flipping by 
MspJI was therefore unexpected and shrugged off as part of the sequence-discrimination 
mechanism.  
The PvuRts1I-family of MDR systems cleaves DNA containing hm5C and 
glucosylated hm5C (ghm5C). AbaSI is a prototypical member and has been extensively 
characterized. It recognizes ghm5C far more efficiently than hm5C or nm DNA by 
selectivity factors of 8000:500:1 respectively (Wang et al., 2011). Like MspJI, AbaSI 
binds its site and cleaves with some variability downstream ~9 bases away on the 
modified strand and ~13 bases away on the complementary strand, leaving a ~9/13 
cleavage product with short 3’-overhangs. Optimal cleavage occurs when two ghm5C 
bases occur 21-23 bp apart on opposite strands (Borgaro et al., 2013). A crystal structure 
of AbaSI in the absence of DNA reveals that it dimerizes through its N-terminal Vsr-
 
 
Figure 12. Crystal structure of AbaSI bound to hm5C DNA. A. Cartoon representation of AbaSI 
bound to hm5C DNA shown in two, perpendicular orientations. Two dimers are shown bound to 
DNA (Green+Blue and Magenta+Yellow) The bound DNA is colored light blue. B. Zoomed in 
view of the hm5C (yellow) found intra-helically. The conserved hm5C binding cavity in the SRA 
domain is shown in sticks and colored green. 
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like endonuclease domain and that the C-terminus adopts an SRA domain (Horton et 
al., 2014). Dimerization spatially orients the hm5C binding pockets within the SRA 
domains by ~70 Å which is consistent with the ~22 bp separation of its binding sites. A 
complementary crystal structure in the presence of hm5C DNA shows two dimers in the 
asymmetric unit nonspecifically interacting with DNA with the modified base 
remaining intra-helical (Figure 12A) (Horton et al., 2014). Interestingly, both the 
endonuclease and hm5C binding sites are localized far from the DNA and suggest 
significant conformational changes or DNA bending are required for a cleavage 
competent complex to form (Figure 12B).  
Another Type IV MDR, GmrSD, has been identified to target and cleave hm5C 
and ghm5C DNA. GmrSD is comprised of two subunits, GmrS and GmrD, encoded by 
the gmrS and gmrD genes respectively (Bair et al., 2007). In most bacteria, however, 
the gmrS and gmrD genes are fused together and encode for a single-chain protein. In 
the absence of an atomic resolution structure, bioinformatic and mutational studies 
suggest that GmrSD contain two conserved protein domains, an N-terminal DUF and a 
proposed C-terminal HNH nuclease. Interestingly, while no NTPase is predicted within 
GmrSD, its cleavage activity has been shown to be stimulated by the presence of 
ATP/GTP (He et al., 2015). Although little is known about GmrSD function, the T4 
phage encoded protein, Internal Protein I* (IPI*), has been demonstrated to bind and 
inhibit GmrSD (Bair et al., 2007). Additional phage encoded inhibitors of MDR systems 
have been identified, including the anti-restriction nuclease (Arn), that can inhibit 
McrBC function (Dharmalingam et al., 1982). The structure of Arn reveals it is a DNA 
mimetic that potentially disrupts McrBC function by precluding DNA binding (Ho et 
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al., 2014). Analysis of these MDR systems and their inhibitors reveals an evolutionary 
pathway that has elaborated a diverse and specific set of coevolving attack and defense 
structures. They are of extreme interest to researchers in the field as they provide a 
weakness that can potentially be exploited for therapeutics to improve the efficacy of 
phage therapy. 
 
PHAGE EXCLUSION SYSTEMS 
All the systems described up to this point, including RM and MDR systems, are 
colloquially defined as ‘restriction’ systems. The term ‘exclusion’, however, is a more 
general term that describes the inability of a phage to successfully infect bacteria, 
whereas ‘restriction’ is used to describe specific nuclease digestion of invading DNAs. 
It can therefore be stated that all restriction systems are exclusion systems, but not all 
exclusion systems are restriction systems. Several such exclusion systems have been 
previously characterized and include Rex, PrrC, Lit and BREX. Phage exclusion by 
these systems is achieved by activation of a prophage-encoded toxin that mediates 
bacterial cell death, thereby preventing viral propagation (Snyder et al., 1995; 
Gottesman et al., 1998).  
The Rex system is comprised of the two proteins, RexA and RexB, encoded by 
the rexA and rexB genes of bacteriophage  respectively. Together they create a two-
component system that aborts lytic growth of bacterial viruses. Low levels of RexB are 
expressed in the lysogenic state and increased 2 to 10-fold after superinfection by a 
competing phage (Parma et al., 1992). Previous biochemical characterization of RexB 
suggests it to be a polytopic transmembrane protein that forms ion channels in response 
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to lytic phage growth, thereby depolarizing the cell and inducing altruistic cell death 
(Parma et al., 1992). The role of RexA in phage exclusion has been less clear. 
Overexpression of RexA in the presence of RexB elicits an exclusion-like response in 
uninfected cells (Snyder et al., 1989). This led researchers to hypothesize RexA would 
localize to RexB thereby activating its ion channel activities. Recent studies in our lab, 
however, suggest that RexA may be acting independently of RexB and instead interacts 
with the cI repressor protein that represses lytic promoters in the  lysogen. Further 
studies are being conducted to probe this mechanism. 
PrrC is a tRNALys anticodon nuclease (ACNase) encoded by the optional E. coli 
prr locus. Its ACNase activity is silenced via association with the REase EcoprrI. A 
phage T4-encoded inhibitor of EcoprrI, Stp, activates the latent ACNase activity 
resulting in cleavage of the tRNALys thereby resulting in cell death and phage exclusion 
(Levitz et al., 1990). Lit is a protease encoded by e14, a cryptic prophage element in 
EcoK12. Although Lit is constitutively expressed in E. coli, it lies dormant in the 
absence of its activator, the Gol sequence of the T4 phage capsid protein, gp23 (Yu and 
Snyder, 1994; Vallee and Auld, 1990). Activation of Lit by gp23 results in cleavage of 
the TGITI motif of Ef-Tu, inhibiting protein synthesis and blocking viral replication 
(Bergsland et al., 1990). 
 The Pgl (phage growth limitation) system of Streptomyces coelicolor is another 
exclusions system that affects the growth of phage C31. It consists of the four genes 
pglWXYZ, where PglW may be a kinase, PglX is a SAM-dependent MTase, PglY is an 
ATPase, and PglZ is an alkaline phosphatase (Hoskisson et al., 2015). The current 
model of this system suggests that PglXZ act as a toxin-antitoxin pair such that release 
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of PglX in C31-infected cells is controlled by PglZ and leads to formation of active 
RM complexes (Hoskisson et al., 2015). Recent bioinformatic analysis of prokaryotic 
defense islands revealed overrepresentation of genes encoding PglZ homologs and has 
been renamed BREX (for bacteriophage exclusion) (Makarova et al., 2011; Goldfarb et 
al., 2015). Introduction of BREX into Bacillus cereus without its own brx genes resulted 
in increases levels of resistance against diverse phages where phage replication was 
blocked without restriction (Gordeeva et al., 2019). Counterintuitively, the host 
genomic DNA was also methylated while the phage genome remained unmethylated. 
The overall mechanism of how BREX excludes phage remains to be seen. 
 
CRISPR-CAS 
CRISPR-Cas (clustered regularly interspaced short palindromic repeats) 
systems are prokaryotic, adaptive immune systems originally discovered in 1987 by 
Yoshizumi Isino and others (Ishino et al., 1987). They function in two major steps: 
1. Acquisition of phage sequences – The Cas1-Cas2 proteins target the phage DNA 
and excise a small fragment, called a protospacer. The protospacer is then integrated 
within a repeating CRISPR array within the host genome next to a PAM 
(protospacer adjacent motif) site (Ishino et al., 2018). 
2. Immunity against reinfection – Upon reinfection, the CRISPR array is transcribed 
into short RNA sequences used by the Cas9 protein. Cas9 can then utilize the RNA 
sequence as a targeting mechanism to the re-infecting DNA for cleavage (Ishino et 
al., 2018). 
CRISPR-Cas varies from canonical RM and MDR systems in that they use 
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complementary RNA to accomplish specificity instead of protein-DNA interactions. 
Since its discovery, the CRISPR-Cas system has been heavily engineered as a molecular 
tool for gene editing.  
 
SIGNIFICANCE 
Although the bacterial defense systems discussed above yield significant insight 
into their mechanisms of action, they represent only a handful of the thousands of 
systems known. In the context of bacterial restriction systems, the aim to understanding 
their function is largely 2-fold: 
First, evolutionarily, it has been challenging for bacteria to adapt different site-
specific targets. This is due to the targeted recognition of the REase and MTase acting 
at the same site. For instance, if the REase evolved a different specificity, then the 
MTase would lag and the host would die due to improper methylation (or vice versa). 
It is therefore not surprising that for a simple six bp recognition site which contains a 
possible 46 (4,096) possible sequences, that only several hundred REases exist with 
different specificities and that the majority of newly discovered REases are 
isoschizomers (REases with the same specificity). Concomitantly, MDR systems have 
been routinely used in analyzing the methylation status of genomic DNA, making it an 
important diagnostic tool for epigenetic disorders. The strict regulations underlying 
MDR function renders each system useful for only a few specific applications (e.g. 
McrBC is limited to modified cytosine restriction of bases separated great than 40-60 
bp apart). Their broad use as molecular tools makes them an attractive topic for research 
and engineering to widen the range of potential applications (i.e. increasing useable site 
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specificities or modifications).  
Second, the increasing rate of exchange of antibacterial resistance genes is 
steadily growing out of control. The emergence of antibiotic resistant, superbug-related 
infections is either difficult or impossible to treat. As such, there is a pressing urgency 
to find alternative approaches to treating bacterial infection. Phage therapy is one 
possibility; however, the bacterial defense mechanisms must be overcome for an 
effective therapeutic to be created. Understanding the function of bacterial defense 
systems can therefore be exploited to create new drugs or inhibitors to render them less 
effective. The presence of phage encoded inhibitors, such as IPI* against GmrSD or Arn 
against McrBC, provides insight into possible mechanisms of inhibition of these 
systems (Bair, 2007; Dharmalingam, 1982; Ho, 2014). 
The objective of my work described in this document aims to elucidate the 
molecular underpinnings of McrBC function. I specifically explore the evolutionary 
divergence of DNA recognition of McrB homologs by using a combination of structural 
biology, biochemistry, and molecular biology. To this end, I have solved the crystal 
structure of the Helicobacter pylori LlaJI N-terminal domain (Hp136), the 
Thermococcus gammatolerans McrB N-terminal domain (Tg185), and the 
Staphylothermus marinus McrB N-terminal domain (Sm3-180). Hp136 is shown to 
adopt a B3 domain used for site-specific recognition (Chapter 2), Tg185 has coopted 
a YTH domain for m6A DNA binding (Chapter 3), and Sm3-180 has coopted an EVE 
domain for non-specific DNA binding (Chapter 4). Together, these data suggest that 
McrBC is inherently a modular restriction system that can adapt unique N-terminal 
domains to alter its specificity. I have additionally solved the crystal structure of the 
 34 
LlaI.2 GTP-specific AAA+ protein that reveals the molecular determinants of GTP 
specificity and hydrolysis in McrB homologs (Appendix 1). 
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ABSTRACT 
Restriction modification systems consist of an endonuclease that cleaves foreign DNA 
site-specifically and an associated methyltransferase that protects the corresponding 
target site in the host genome. Modification-dependent restriction systems, in contrast, 
specifically recognize and cleave methylated and/or glucosylated DNA. The LlaJI 
restriction system contains two 5-methyl-cytosine (5mC) methyltransferases (LlaJI.M1 
and LlaJI.M2) and two restriction proteins (LlaJI.R1 and LlaJI.R2). LlaJI.R1 and 
LlaJI.R2 are homologs of McrB and McrC respectively, which in Escherichia coli 
function together as a modification-dependent restriction complex specific for 5mC-
containing DNA. Lactococcus lactis LlaJI.R1 binds DNA site-specifically, suggesting 
that the LlaJI system uses a different mode of substrate recognition. Here we present the 
structure of the N-terminal DNA binding domain of Helicobacter pylori LlaJI.R1 at 
1.97Å resolution, which adopts a B3 domain fold. Structural comparison to B3 domains 
in plant transcription factors and other restriction enzymes identifies key recognition 
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motifs responsible for site-specific DNA binding. Moreover, biochemistry and 
structural modeling provide a rationale for how Helicobacter pylori LlaJI.R1 may bind 
a target site that differs from the five base pair sequence recognized by other LlaJI 
homologs and identify residues critical for this recognition activity. These findings 
underscore the inherent structural plasticity of B3 domains, allowing recognition of a 
variety of substrates using the same structural core. 
 
INTRODUCTION 
Classical restriction modification (RM) systems are ubiquitous in bacteria and act as a 
requisite layer of defense against predatory bacteriophage viruses (1). These systems 
consist of a restriction endonuclease and a methyltransferase, which provide the dual-
function of cleaving exogenous DNA site-specifically while protecting the host genome 
via methylation of the corresponding recognition sequence (2). Three variants of RM 
systems – type I, type II, and type III – have been identified and differ in their structural 
composition and mechanism of restriction. Type I systems are multifunctional 
complexes containing separate restriction, methylation, and DNA-sequence recognition 
subunits. These machines require Mg2+ and ATP, catalyze both restriction and 
methylation, and cut DNA non-specifically far from their recognition sites (3). Type II 
systems are the simplest, generally existing as dimers that carry out the recognition and 
restriction activities. These enzymes do not require ATP and have a separate, associated 
methyltransferase (4). Homodimeric type II restriction enzymes recognize DNA 
sequences that are symmetric while those that are heterodimeric can bind asymmetric 
sequences (5). Type III systems contain separate modification (Mod) and restriction 
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(Res) subunits that form homodimeric Mod2 and a heterotetrameric Res2Mod2 
complexes and catalyze both restriction and methylation in a Mg2+ and ATP-dependent 
manner (6).  They differ from type I systems, however, in that they require two inversely 
oriented recognitions sites that can vary in their spatial separation (7). 
Modification-dependent restriction systems (MDRS) – colloquially referred to 
as type IV systems – recognize and cleave modified DNA (8). McrA and McrBC are 
prototypical MDRSs that target DNA containing 5-methylcytosine (5mC) and 5-
hydroxymethylcytosine (5hmC) (9, 10, 11, 12, 13, 14). McrA is a small, dimeric protein 
that recognizes the symmetrically methylated sequence Y5mCRG (15). The McrB and 
McrC proteins together form a conserved, two-component restriction complex capable 
of long range DNA translocation similar to type I and type III enzymes. Escherichia 
coli (Ec) McrB contains an N-terminal DNA binding domain (12) and a C-terminal 
AAA+ motor domain that hydrolyzes GTP and mediates nucleotide-dependent 
oligomerization into heptameric rings (16). McrB’s basal GTPase activity is stimulated 
via interaction with its partner endonuclease McrC (13), which cannot bind DNA on its 
own and in vitro only associates with the McrB oligomer (17). Biochemical studies 
suggest a model for DNA cleavage in which McrB and McrC assemble at two distant 
RMC sites (where R is a purine, and MC is a methylcytosine) and translocate in a manner 
that requires stimulated GTP hydrolysis (10, 18). Collision of McrBC complexes 
triggers cleavage of both DNA strands close to one of the RMC sites (14, 19). Other 
MDRS families display a variable spectrum of specificity for different modifications. 
These include MspJI, which recognizes 5mC and 5hmC (20), the PvuRts1I family, 
whose members show unique individual specificities for 5hmC and/or 5-
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glucosylhydroxymethylcytosine (5ghmC) (21), and GmrSD, which recognizes 5ghmC 
(22). Structural studies of McrB, MspJI, PvuRtsI, and AbaSI suggest type IV systems 
employ a generalized base-flipping mechanism for recognition of the modified DNA 
(23, 24, 25, 26, 27).  
The LlaJI restriction cassette was first identified in Lactococcus lactis on the 
naturally occurring plasmid pNP40 and shown to confer resistance against common 
lactococcal phages (28). It consists of an operon encoding two 5mC-methyltransferases, 
LlaJI.M1 and LlaJI.M2, and two restriction proteins, LlaJI.R1 and LlaJI.R2, both of 
which are absolutely required for restriction activity in vivo (29). The M1 and M2 
methyltransferase activities modulate expression of LlaJI operon in vivo (30). Although 
formally classified as a type II R/M system (REBASE enzyme # 10100, NEB), LlaJI.R1 
and LlaJI.R2 share domain homology with McrB and McrC respectively. R1 contains 
sequence motifs that identify its C-terminal portion as a GTP-specific AAA+ domain 
and R2 contains a conserved C-terminal PD-(D/E)xK endonuclease domain. These 
features suggest LlaJI enzymes function more like McrBC than other Type II systems.  
Unlike McrB, however, L. lactis LlaJI.R1 binds DNA site-specifically, 
recognizing the asymmetric 5’-GACGC-3’ sequence in one strand and 5’-GCGTC-3’ 
in the other strand (29). Other LlaJI homologs have been identified in Helicobacter 
pylori, Streptococcus pyogens, Bacillus cereus, and Clostridium cellulovorans (29, 31). 
Of these, Clostridium cellulovorans LlaJI has also been shown to target the same 
asymmetric, five base pair sequence (Yang, et al. 2016). How LlaJI proteins recognize 
DNA site-specifically is unknown. Here we present the structure of the N-terminal DNA 
binding domain of Helicobacter pylori LlaJI.R1 (HpR1∆136) at 1.97 Å resolution, 
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which adopts a B3 domain fold. Structural comparison to B3 domain-containing plant 
transcription factors and restriction endonucleases identifies the key recognition motifs 
responsible for site-specific DNA binding. Additional evidence from biochemistry and 
structural modeling argues that HpLlaJI.R1 binds a target site that differs from the five 
base pair sequence recognized by the Lactococcus lactis and Clostridium cellulovorans 
LlaJI homologs. Mutagenesis further identifies residues R17 and R60 as critical 
determinants of HpLlaJI.R1 DNA binding. Together, these findings underscore the 
inherent structural plasticity previously noted for B3 domains, which confers specificity 
to different sequences via the same structural core. 
 
RESULTS 
Structure and topology of the HpLlaJI.R1 N-terminal domain  
Though previous studies show LlaJI.R1 binds DNA site-specifically (29, 31), the 
molecular means through which this is achieved remains unknown. Numerous attempts 
to purify either the full-length Lactococcus lactis LlaJI.R1 or its isolated N-terminal 
DNA binding domain for structural studies were unsuccessful. Bioinformatics identifies 
various other species harboring the LlaJI operon, including Helicobacter pylori (Hp) 
(29). Computational analyses of these homologs by fold matching and structural 
prediction algorithms failed to identify a reliable template for modeling DNA 
interactions. To understand how the LlaJI.R1 binds DNA site-specifically, we therefore 
crystallized the N-terminal domain of HpLlaJI.R1 (HpR1∆136) and determined its 
structure at 1.97 Å by selenium SAD phasing (32) (Fig. 1). 
HpR1∆136 crystallizes in the space group P1 with four molecules (A-D) in the 
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asymmetric unit organized as two homodimers packed end to end, with molecules A 
and B and molecules C and D pairing together (Fig. 1A). These dimers superimpose 
with an RMSD of 0.589Å. Each HpR1∆136 monomer consists of a core six-stranded  
sheet that folds into a pseudo-beta barrel flanked on four separate edges by alpha helices 
(1-4) (Fig. 1B,C). An additional -strand (7) inserts at the dimer interface and 
breaks the symmetry, adopting an antiparallel configuration with 1B/1D and a parallel 
configuration with 1A/1C (Fig. 1B,C). Clear connectivity between 7 and 4 can be 
traced in molecule B (Fig. 1D). Structural superposition of the two asymmetric dimers 
suggests 7 is connected in the same manner in molecule D despite the lack of density 
for the 4-7 loop (Fig. 1E). We observe no density for the corresponding 7 strands 
in either molecule A or molecule C.  
7 residues L127 and F129 interact with a hydrophobic cluster sandwiched 
between 1 and the amphipathic 2 helix in each monomer (Fig. 2A). I24, H27, and 
F28 in 2 and V115, L116, and L119 in 4 provide additional stabilizing contacts 
across the dimer interface (Fig. 2A,B). 7 insertion helps space these elements and 
prevent steric clashing that otherwise would occur. A total interaction surface of 800 
Å2 is shared between the monomers. Size exclusion chromatography coupled to multi-
angle light scattering (SEC-MALS) indicates HpR1∆136 dimerizes in solution (Fig. 
2C), suggesting the observed molecular organization in the crystal lattice is not simply 
a packing artifact. Deletion of 7 renders HpR1∆136 insoluble. Point mutations at the 
dimer interface in 2 (I24N, H27E, F28E) and 4 (L116E and L199E) displayed similar 
insolubility phenotypes and could not be purified. Only the V115N mutant retained 
 52 
solubility and, like wildtype, forms a stable dimers in solution when analyzed by SEC-
MALS (Fig. 3A). These data support the notion that HpR1∆136 dimerization is required 
for stability and biologically relevant. 
 
HpR1∆136 adopts a B3 domain fold  
The DALI alignment algorithm (33) identifies several structural homologs of 
HpR1∆136. These include the DNA binding domain of the Arabidopsis thaliana (At) 
auxin-dependent transcription factor ARF1 (PDB ID: 4ldx, Z-score = 8.6, RMSD = 3.0), 
the C-terminal fragment of the BfiI restriction endonuclease (PDB ID: 3zi5, z-score = 
9.7, RMSD = 2.1), and the N-terminal fragment of the EcoRII restriction endonuclease 
(PDB ID: 3hqf, z-score = 8.1, RMSD = 2.7). Each is comprised of a B3 domain (34, 35, 
36, 37, 38). B3 domains share a common pseudo-barrel architecture (SCOP number 
101935) and act as recognition modules that bind DNA site-specifically (39). Structural 
superposition confirms HpR1∆136 similarly adopts a B3 domain fold (Fig. 4A, Fig. S1). 
Importantly, this fold is structurally distinct from the analogous region in EcMcrB, 
which preferentially binds DNA containing methylated cytosines. 
B3 domains contain two critical regions that confer DNA target site specificity. 
These recognition motifs, termed the N-arm and C- arm, reside on opposite edges of the 
pseudo-barrel core and form a wrench-like structure that contacts the major groove (36, 
37, 40). In this arrangement, the N-arm specifically associates with the 5’-half of the 
target site and the C-arm engages the 3’-half. Comparison to the DNA-bound AtARF1 
structure identifies these key features within the HpR1∆136 model: the N-arm 
encompasses the 1-2 loop and the 1 helix and the C-arm localizes to the 3-4 loop 
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(Fig. 1C, Fig. 4B). Both proteins display a comparable electrostatic surface, with an 
extensive basic patch positioned between the N- and C-arms and coincident with the 
DNA binding face of AtARF1 (Fig. 4C). This mode of substrate binding is conserved 
among DNA-bound B3 domain structures and is consistent with other HpR1∆136 
structural superpositions (Fig. S1). An exception is the B3 domain of NgoAVII, whose 
orientation on DNA is inverted such that the N-arm associates with the 3’ half of the 
target site and the C-arm with the 5’ half (40).  
The BfiI contains other unique motifs (termed the N- and C-loops) that provide 
additional phosphate backbone and minor groove interactions (37). These are shortened 
in EcoRII and absent in all previously characterized plant B3 domains (36, 38, 41, 42, 
43). HpR1∆136 similarly lacks these segments, suggesting it either evolved from a more 
simplified common ancestor or lost these segments over time due to a lack of selective 
pressure.  
The putative DNA binding surface of each HpR1∆136 monomer faces away 
from the dimer interface, suggesting that HpR1∆136 has the capacity to bind two DNA 
target sites simultaneously. The asymmetric orientation of the 7 strand, however, 
positions E131 close to one of the binding sites and alters its surface charge potential in 
a manner that makes it less basic (Fig. 4D). This intrinsic difference would allow one 
monomer to bind more efficiently and could bias the arrangement of HpLlaJI on DNA.  
All previously characterized B3 domains exist as monomers (36, 37, 38, 39, 40, 
41, 42, 43, 44). To understand what hinders dimerization in these contexts, we 
superimposed the coordinates of other B3 domains onto our HpR1∆136 dimer and 
examined the orientation of secondary structure features relative to the dimer interface 
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(Fig. 5). Although EcoRII and BfiI have structurally equivalent -strands that partially 
align with 7, they also contain helical segments that sterically prevent two monomers 
from coming together (Fig. 5A,B). The 1 helices of VRN1 and UbaLAI would 
similarly clash and block dimerization (Fig. 5C, D). AtARF1, NgoAVII, RAV1, and 
At1g16640.1, in contrast, all lack a corresponding 7 strand (Fig. 5E-H), suggesting 
monomers cannot be properly spaced to avoid collision. The stabilizing hydrophobic 
interactions provided by 7 would also be absent. These observations highlight the 
importance of secondary structure features in modulating the oligomeric state of B3 
domains and will be useful for predicting interactions in other uncharacterized proteins 
that contain this conserved fold. 
 
HpR1∆136 structure provides model for site specific binding 
Previous biochemical and genetic studies indicate that Lactococcus lactis and 
Clostridium cellulovorans LlaJI target the five base pair sequence 5'-GACGC-3' (29, 
31). HpR1∆136 shows weak affinity for DNA containing this sequence (Ll) when 
assessed by filter binding (Fig. 6A, blue). Scrambling the putative binding sequence 
(Llscr) has no effect on the affinity (Fig. 6A, green), suggesting this represents the basal 
level for non-specific DNA binding by HpR1∆136. EcMcrB, in contrast, preferentially 
binds 5mC-containing DNA (5mC) but does not bind a non-methylated version of the 
same substrate (nm) under the same assay conditions (Fig. 6A, black versus red). 
EcMcrB similarly does not bind either the Ll or Llscr substrates (Fig. 6A, yellow and 
orange), underscoring how its binding depends on the presence of methylated cyotsines. 
Unexpectedly, HpR1136 showed enhanced affinity for the E. coli specific 5mC 
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and nm substrates (Fig. 6A, light blue and purple) relative Ll and Llscr substrates. We 
attribute this to subtle sequence differences as the binding is independent of methylation 
status. The 5mC and nm substrates likely contain sequence fragments that more closely 
mimic that preferred recognition site of HpR1.LlaJI, which is distinct from both 
EcMcrB and other LlaJI homologs. 
Despite a common fold, B3 domains exhibit divergent sequence preferences. 
Previous structural and biochemical data show that the C-arm length can influence the 
length of the recognized target site (Fig. 6B). A longer C-arm is excluded from the major 
groove (Fig. 6C), decreasing the overall binding footprint and biasing recognition 
towards a five base pair site (36, 37). A shorter C-arm affords greater access to the DNA 
bases, which in some instances increases the number of specific contacts and extends 
the target site to six bases (37, 38). The amino acid composition of the N- and C-arms 
ultimately dictates specificity, however, and thus some B3 domains with shorter C-arms 
still bind five base pair sites (40, 44). Structural superposition reveals shorter C-arm in 
HpR1∆136 (Fig. 6C).  
In the absence of a DNA bound complex and without explicit knowledge of the 
HpLlaJI target site, we used the AtARF1-DNA structure as a proxy to identify side 
chains that might contribute to specificity. The N-arm residue H136 and C-arm residues 
R181, P184, and R186 are critical for AtARF1 DNA binding (Fig. 6D). Structural 
modeling reveals similar residues in HpR1∆136 (Fig. 6E), with H14 and R17 in the N-
arm and P59 and R60 in the C-arm poised to provide base-specific contacts. 
Interestingly, R17 is spatially oriented like R181 in AtARF1, hinting that it would 
contact the 3’-half of the target site despite being localized in the N-arm.  
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To confirm the significance of our structural modeling, we mutated the predicted 
binding residues in HpR1∆136 and assessed how each substitution affects interaction 
with the E. coli specific nm DNA substrate via filter binding (Fig 6F). H14A (red), 
R17A (orange), and R60A (light blue) mutations show a marked decrease in affinity for 
nm DNA versus wildtype (WT, purple), while P59A (green) shows less of an effect. 
The R17A/R60A double mutant (brown) completely abolishes binding. This finding 
was corroborated using electrophoretic mobility shift assays (EMSAs) to measure the 
association of   HpR1136 with digested, non-methylated -phage DNA (Fig. 7). We 
observe a significant gel shift with wildtype HpR1∆136. H14A and P59A show similar 
shifts in this assay while the individual R17A and R60A substitutions produce a 
moderate reduction in binding. The R17A/R60A double mutant, however, significantly 
impairs binding (Fig. 7), similar to its effects on the nm DNA substrate in the filter 
binding assay (Fig. 6F). All of these mutants form stable dimers in solution (Fig. 3B), 
arguing that their effects are not due to global structural perturbations. Together these 
data implicate R17 and R60 as critical determinants of HpR1∆136 DNA binding. 
B3 domains contain conserved residues that associate with ‘clamp’ phosphates 
at the 5’ ends of each strand in the target site (37). R177 and K126 form these 
interactions in AtARF1 (R81 and K23 in EcoRII; R272 and K340 in BfiI; K27 and K82 
in UbaLAI; K212 and K275 in R.NgoAVII). In HpR1∆136, R6 is poised to act on one 
strand while K50 could perform a similar function on the opposing strand. K50 is 
positioned away from the modelled DNA backbone in the apo state and may be 
reoriented upon target recognition. Conformational rearrangements in the BfiI and 
R.NgoAVII B3 domains have previously been observed upon DNA binding (35, 37, 
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40). 
 
DISCUSSION 
Here we described the structure of the HpLlaJI.R1 DNA binding domain and 
demonstrated that it adopts a B3 domain fold. B3 domains are prevalent among bacterial 
restriction endonucleases and plant transcription factors, where they function as site-
specific DNA binding modules (37, 39, 45). Previous crystallographic studies revealed 
that the N- and C-arms determine the specificity of each individual B3 domain and 
confer structural plasticity to the conserved core scaffold (36, 37, 38, 40, 43). Our 
structural data and modeling identifies the N- and C-arms in HpR1∆136 along with key 
residues that likely form direct contacts with the DNA backbone, clamp phosphates, and 
specific bases. HpR1∆136 has weak affinity for DNA containing the asymmetric five 
base pair site that other LlaJI homologs target (29, 31) and a surprisingly stronger 
affinity for the EcMcrB-specific DNA substrates, regardless of their methylation status 
(Fig. 6A). We note that HpR1∆136 contains a shorter C-arm and thus could potentially 
bind a six base pair site. While further studies are required to pinpoint the target site of 
HpLlaJI.R1, our findings offer a general model for site-specific binding and provide a 
structural explanation for why LlaJI homologs do not target modifications despite 
sharing a similar domain organization with McrBC. 
Importantly, we identify the N-arm R17 and C-arm R60 residues as critical 
determinants of DNA binding and specificity in HpR1∆136. Individual point mutations 
at these positions display moderate defects while a combined double mutant completely 
abolishes DNA binding in all assays tested (Figs. 6F and 7). The H14A and P59A 
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mutations show varying effects depending on the specific substrate used and the 
sensitivity of the assay. While H14 and P59 may also impart specific binding 
interactions, their contribution is likely context dependent.  
HpLlaJI.R1 is unique in that its isolated B3 domain dimerizes, both in solution 
(Fig. 2C) and in crystallo (Fig. 1). 7 is absolutely essential for HpR1136 dimerization 
and structural stability, as a truncation of this motif renders the protein insoluble. Our 
structure shows that direct dimerization of other B3 domains is hindered by either (i) 
the intrinsic lack of a structurally equivalent 7 strand or (ii) the presence of additional 
helical motifs at the N- or C-terminus that sterically clash with 7 or 4 at the dimer 
interface (Fig. 5). Dimerization of other B3 domain-containing proteins instead occurs 
through additional structural elements. For instance, AtARF1 monomers associate 
through a separate dimerization domain, which facilitates cooperative binding of the B3 
domains to two anti-parallel 5’-TGTCTC-3’ sites on opposing strands (38). BfiI, 
EcoRII, and R.NgoAVII also dimerize but through their respective nuclease domains 
(34, 35, 40). These observations will help in classifying uncharacterized B3 domains 
and predicting their architectural organization. 
Our structural data show that the 7 strand from one HpR1∆136 monomer is 
asymmetrically stabilized at the dimer interface while the corresponding region in the 
other monomer remains disordered. The orientation of this strand dictates the 
electrostatic landscape on the dimer surface, making the DNA binding site in one 
monomer more basic than the other. While we cannot completely rule out that this is an 
artifact of crystallization, an analogous phenomenon was noted in the rotavirus A non-
structural protein 3 (NSP3) homodimer (46). There the asymmetric stabilization of a 
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helix from one monomer creates a single positively charged binding site that ultimately 
leads to a stoichiometry of 2:1 NSP3:viral mRNA (46). We speculate that HpLlaJI.R1 
may bind DNA with a similar 2:1 stoichiometry, but that only one B3 domain will 
directly contact the target site.  
Asymmetric binding could have important implications for the assembly of a 
cleavage-competent LlaJI restriction complex. Like McrB, LlaJI.R1 contains a 
conserved GTP-specific AAA+ domain at its C-terminus (29). EcMcrB forms 
heptameric rings in the presence of GTP and this oligomerization is critical for 
recruiting its partner endonuclease McrC (16), which cannot bind DNA on its own and 
preferentially associates with the assembled AAA+ domain (17). While the exact 
organization of McrBC on DNA has yet to be elucidated, biochemical and structural 
studies have shown the EcMcrB N-terminal domain binds a single methylated cytosine 
via base flipping (23). The intrinsic asymmetry of the McrBC complex therefore 
imposes constraints on how the individual subunits interact with the RMC site and 
suggests that some monomers are directly engaged while others are not. The asymmetric 
HpR1∆136 dimer could reflect a similar structural constraint in the LlaJI system 
wherein the alternative positioning of the 7 strand dictates which monomers bind the 
target sequence. Further structural characterization of both systems will be necessary to 
parse out how substrate binding, GTP-dependent assembly, and nuclease recruitment 
are coordinated in each case. Although LlaJI and McrBC differ in their specificity and 
targeting, we predict the general molecular mechanisms governing the function of LlaJI 
and McrBC will be conserved. 
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EXPERIMENTAL PROCEDURES 
Cloning, expression and purification HpLlaJI.R1 constructs 
DNA encoding the Helicobacter pylori LlaJI.R1 protein (DOE IMG/M ID 637022177) 
was codon optimized for E. coli expression and synthesized commercially by Bio Basic 
Inc. DNA encoding the N-terminal domain (HpR1∆136; residues 1-136) was amplified 
by PCR and cloned into pET21b, introducing a 6xHis tag at the C-terminus. 
Selenomethionine labeled (SeMet) HpR1∆136 was expressed in minimal media using 
methionine auxotrophs (T7 Express Crystal Competent E. coli, New England Biolabs) 
according to manufacturer protocols. Native HpR1∆136 was transformed into 
BL21(DE3) cells, grown at 37°C in Terrific Broth to an OD600 of 1.0, and then induced 
with 0.3 mM IPTG overnight at 19°C. All cells were harvested, washed with nickel load 
buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 30 mM imidazole, 5% glycerol (v:v), 
and 5 mM -mercaptoethanol), and pelleted a second time. Pellets were typically flash 
frozen in liquid nitrogen and stored at -80°C.  
Thawed pellets from 500 ml cultures were resuspended in 30 ml of nickel load 
buffer supplemented with 10 mM PMSF, 5 mg DNAse (Roche), 5 mM MgCl2, and a 
Roche complete protease inhibitor cocktail tablet (Roche). Lysozyme was added to 1 
mg/ml and the mixture was incubated for 15 minutes rocking at 4°C.  Cells were 
disrupted by sonication and the lysate was cleared of debris by centrifugation at 13 000 
rpm (19 685 g) for 30 minutes at 4°C. For native and SeMet HpR1∆136, the supernatant 
was filtered, loaded onto a 5 ml HiTrap chelating column charged with NiS04 and then 
washed with nickel load buffer. Hp∆136 was eluted with an imidazole gradient from 30 
mM to 1 M. Pooled fractions were dialyzed overnight at 4°C into SP loading buffer (20 
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mM HEPES pH 7.5, 50 mM NaCl, 1 mM EDTA, 5% glycerol (v:v), and 5 mM DTT). 
The sample was applied to a 5 ml HiTrap SP HP column equilibrated with SP loading 
buffer and then washed with SP loading buffer. HpR1∆136 was eluted with a NaCl 
gradient from 50 mM to 1 M. Pooled fractions were concentrated and further purified 
by size exclusion chromatography (SEC) using a Superdex 200 10/300 column. All 
proteins were exchanged into a final buffer of 20mM HEPES pH 7.5, 150mM KCl, 5 
mM MgCl2, and 1mM DTT (5mM for SeMet labelled) during SEC and concentrated to 
5-40 mg/ml. Concentrations of purified proteins were determined by SDS-PAGE and 
densitometry compared against BSA standards. All amino acid substitutions were 
introduced into HpR1136 in pET21b by Quikchange PCR and mutant proteins were 
purified as described for wildtype. 
 
Cloning, expression and purification EcMcrB 
DNA encoding the Escherichia coli McrB protein (Uniprot P15005) was codon 
optimized for E. coli expression and synthesized commercially by GENEART. DNA 
encoding the full-length protein (EcMcrB FL) was amplified by PCR and cloned into 
c2xP, a modified pMAL c2x vector with an HRV3C protease site replacing the Factor 
Xa site directly upstream of the mcrB gene. Native EcMcrB FL expressed as N-terminal 
maltose binding protein fusion in BL21(DE3) cells. Transformed cells were grown at 
37°C in Terrific Broth to an OD600 of 0.8-1.0, and then induced with 0.3 mM IPTG 
overnight at 19°C. All cells were harvested, washed with amylose loading buffer (20 
mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol (v:v), 1 mM EDTA, and 1 mM DTT), 
and pelleted a second time. Pellets were typically flash frozen in liquid nitrogen and 
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stored at -80°C.  
Thawed pellets from 500 ml cultures were resuspended in 30 ml amylose 
loading buffer supplemented with 10 mM PMSF, 5 mg DNAse (Roche), 5 mM MgCl2, 
and a Roche complete protease inhibitor cocktail tablet (Roche). Lysozyme was added 
to 1 mg/ml and the mixture was incubated for 15 minutes rocking at 4°C. Cells were 
disrupted by sonication and the lysate was cleared of debris by centrifugation at 13 000 
rpm (19 685 g) for 30 minutes at 4°C. The supernatant was filtered, loaded onto 40 ml 
of packed amylose resin (New England Biolabs) and then washed with amylose loading 
buffer. EcMcrB FL was eluted with amylose loading buffer supplemented with 10 mM 
D-maltose. Hrv3C protease was added to pooled fractions and dialyzed overnight at 4°C 
into Q loading buffer (20 mM Tris-HCl pH 8.0, 50 mM NaCl, 1 mM EDTA, 5% glycerol 
(v:v), and 1 mM DTT). The sample was applied to a 5 ml HiTrap Q HP column 
equilibrated with Q loading buffer and then washed with Q loading buffer. EcMcrB FL 
was eluted with a NaCl gradient from 50 mM to 1 M. Pooled fractions were concentrated 
and further purified by size exclusion chromatography (SEC) using a Superdex 75 10/30 
pg column. All proteins were exchanged into a final buffer of 20mM HEPES pH 7.5, 
150mM KCl, 5 mM MgCl2, and 1mM DTT during SEC and concentrated to 5-40 
mg/ml. 
 
Crystallization, X-ray data collection, and structure determination 
SeMet HpR1∆136 was crystallized by sitting drop vapor diffusion in 0.1 M MMT 
pH6.5, 25% PEG 1,500 (v:v) by mixing 1 L of protein with 1 L of the condition with 
a final drop size of 2 L and reservoir volume of 65 L. Crystals appeared within 2-8 
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days at 20°C. Samples were cryoprotected with Parabar 10312 and frozen in liquid 
nitrogen. Single-wavelength anomalous diffraction (SAD) data of two crystals were 
collected remotely on the tuneable NE-CAT 24-ID-C beamline at the Advanced Photon 
Source at the selenium edge energy at 12.663 kEv (Table 1). Crystal 1 was of the space 
group P1 with unit cell dimensions a = 37.47, b = 44.39, c = 84.78 Å and  = 98.04°,  
= 94.37°,  = 98.52° and showed strong anomalous signal. Crystal 2 was of the space 
group P1 with unit cell dimensions a = 37.53, b = 43.77, c = 85.09 Å and  = 97.87°,  
= 93.86°,  = 97.77°. Both crystals were prepared in the same condition but exhibited 
mosaicities of 0.20871̊ and 0.11033̊ respectively. Data were integrated and scaled using 
XDS (47) and AIMLESS (48) via the NE-CAT RAPD pipeline. Se-SAD phasing with 
the data from crystal 1 yielded an initial model that was incomplete and contained a few 
regions of ambiguity. Heavy atom sites were located using SHELX (49) and phasing, 
density modification, and initial model building was carried out using the Autobuild 
routines of the PHENIX package (50). Further cycles of model building and refinement 
was carried out manually in COOT (51) and PHENIX respectively (50) but failed to 
improve significantly the density and refinement statistics. A more complete model was 
obtained using the diffraction data from crystal 2. The structure was solved by molecular 
replacement with PHASER (52) using the SAD derived structure from crystal 1 as the 
search model. This vastly improved the resulting maps and statistics following 
subsequent rounds of manual model building and refinement. The final model of crystal 
2 was refined to 1.97 Å resolution with Rwork/Rfree = 0.1927/0.2233 (Table 1) and 
contained four molecules in the asymmetric unit: molecule A, residues 1-121; molecule 
B, residues 1-131; molecule C, residues 1-121; molecule D, residues 1-131. Threonine 
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57 exists as a Ramachandran outlier with relatively weak density in the 3-4 loop of 
molecules B and D respectively and could not be refined further. All structural models 
were rendered with Pymol (Schrödinger, Inc.) and surface electrostatics were calculated 
with APBS (53).  
 
Size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS) 
Purified HpR1∆136 at 4mg/mL was subjected to size-exclusion chromatography using 
a Superdex 200 10/300 column (GE) equilibrated in SEC buffer (20mM HEPES pH 7.5, 
150 mM KCl, 5 mM MgCl2, and 1mM DTT). The column was coupled to a static 18-
angle light scattering detector (DAWN HELEOS-II) and a refractive index detector 
(Optilab T-rEX) (Wyatt Technology). Data were collected continuously at a flow rate 
of 0.5 mL/min. Data analysis was carried out using the program Astra VI. Monomeric 
BSA at 4mg/mL (Sigma) was used for normalization of the light scattering detectors 
and data quality control. 
 
Preparation of oligonucleotide substrates 
The following DNA oligonucleotides for filter binding synthesized commercially by 
Integrated DNA Technologies (IDT): 
5mC_us 5’CCGGGTAAGA(5mC)CGGTAGCGAGCCCGG 
5mC_ls 5’CCGGGCTCGCTA(5mC)CGGTCTTACCCGG 
nm_us 5’CCGGGTAAGACCGGTAGCGAGCCCGG 
nm_ls 5’CCGGGCTCGCTACGGTCTTACCCGG 
Ll_us 5’CAGATCTGACGCTAGAGCTT 
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Ll_ls 5’AAGCTCTAGCGTCAGATCTG 
Llscr_us 5’CAGATCTCGACGTAGAGCTT 
Llscr_ls 5’AAGCTCTACGTCGAGATCTG 
 
Lyophilized single-stranded oligonucleotides were resuspended to 1 mM in 10 mM 
Tris-HCl and 1 mM EDTA and stored at -20°C until needed. Single-stranded 
oligonucleotides were 5’ end-labeled with (32P)ATP using polynucleotide kinase 
(New England Biolabs) and then purified on a P-30 spin column (BioRad) to remove 
unincorporated label. Duplex substrates were prepared by heating equimolar 
concentrations of complementary strands (denoted with suffixes ‘us’ and ‘ls’ indicating 
upper and lower strands) to 95°C for 15 minutes followed by cooling to room 
temperature overnight and then purification on an S-300 spin column (GE) to remove 
single stranded DNA. Four duplex DNA substrates were prepared: a methylated 
EcMcrB-specific substrate,  5mC (5mC_us and 5mC_ls); a non-methylated  EcMcrB-
specific substrate, nm (nm_us and nm_ls), a site-specific substrate containing the L. 
lactis LlaJI.R1 binding site, Ll (Ll_us and Ll_ls), and a substrate with the L. lactis 
LlaJI.R1 binding site sequence scrambled as a control. Llscr (Llscr_us and Llscr_ls). 
 
Filter binding assays 
The standard buffer for the DNA binding assays contained 25 mM MES (pH 6.5), 2.0 
mM MgCl2, 0.1 mM DTT, 0.01 mM EDTA, and 40 g/mL BSA. Binding was 
performed with purified HpR1∆136 (wildtype or mutants) or EcMcrB FL at 30°C for 
10 min in a 30 L reaction mixture containing 14.5 nM unlabeled DNA and 0.5 nM 
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labelled DNA. Samples were filtered through KOH-treated nitrocellulose filters 
(Whatman Protran BA 85, 0.45 M) using a Hoefer FH225V filtration device for 
approximately 1 min.  Filters were subsequently analyzed by scintillation counting on a 
2910TR digital, liquid scintillation counter (PerkinElmer). All measured values 
represent the average of at least two independent experiments and were compared to a 
negative control to determine fraction bound. 
 
Electrophoretic mobility shift assays (EMSA) 
The standard buffer for the EMSAs contained 10 mM Tris-HCl pH8.0, 100 mM NaCl, 
1 mM MgCl2, and 1 mM DTT. Binding was performed with purified HpR1136 
(wildtype or mutants) at 25°C for 30 min in a 16 L reaction mixture containing 10 
ng/L of N6-methyladenine-free -phage DNA (New England Biolabs) digested with 
BamHI and NdeI (New England Biolabs) and purified via a NucleoSpin® Gel and PCR 
Clean-Up kit (Machery-Nagel). Following incubation, samples were analyzed by 0.7% 
agarose gel in 1x TAE at 4°C and 80V for 90 min. All gels were stained with SYBR® 
Green in 1x TAE overnight at 25°C (Thermo-Fisher Scientific) and visualized using a 
BioRad Gel DocTM EZ imager system. 
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The atomic coordinates and structure factors (code 6C5D) have been deposited in the 
Protein Data Bank (http://wwpdb.org/). 
 
The abbreviations used are: RM, restriction modification; Mod, modification, Res, 
restriction; MDRS, modification-dependent restriction system; 5mC, 5-methylcytosine; 
5hmC; 5-hydroxymethylcytosine; 5ghmC, 5-glucosylhydroxymethylcytosine; Ec, 
Escherichia coli; RMC, methylated binding site where R is a purine and MC is a 
methylcytosine; Hp, Helicobacter pylori; HpR1∆136, the N-terminal DNA binding 
domain of Helicobacter pylori LlaJI.R1 protein; At, Arabidopsis thaliana; SeMet; 
Selenomethionine; SAD, single-wavelength anomalous diffraction; SEC, size exclusion 
chromatography; MALS, multi-angle light scattering 
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Table 1. Data collection and refinement statistics for HpR1∆136 
Data collection 
     Model Crystal 1 Crystal 2 (PDB ID: 
6C5D)      X-ray Source NECAT 24ID-C NECAT 24I -C 
     Wavelength (Å) 0.9791 0.9791 
     Spacegroup P1 P1 
          a, b, c (Å) 37.47, 44.39, 84.78 37.53, 43.77, 85.09 
          , ,  (°) 98.04, 94.37, 98.52 97.87, 93.86, 97.77 
     Resolution (Å)a 83.53 – 1.93 (2.08 – 1.93) 83.97 – 1.97 (2.10 – 1.97) 
     Mosaicity 0.20871̊ 0.11033̊ 
     No. measured reflectionsa 197952 (30000) 152937 (23180) 
     No. unique reflectionsa 53208 (15168) 41551 (12151) 
     Completeness (%)a 91.5 (91.9) 93.6 (90.1) 
     Multiplicitya 3.72 (1.98) 3.68 (1.91) 
     Rmeas
a 0.072 (0.395) 0.096 (0.624) 
     Mean I/σIa 11.7 (2.54) 9.0 (1.56) 
     CC1/2
a 0.998 (0.903) 0.997 (0.709) 
Phasing 
     Initial F.O.M. 0.548  
     No. Se Sites 4  
Refinement 
     Rwork/Rfree  0.1927/0.2233 
     RMSD   
          Bond lengths (Å)  0.016 
          Bond angles (°)  1.530 
     Ramachandran plot   
          Favored (%)  96.98 
          Allowed (%)  2.62 
          Outliers (%)  0.40 
     Average B-Factor  37.98 
     Clashscore  5.33 
     No. Atoms   
          Macromolecule  4369 
          Solvent  245 
a Denotes values for the highest resolution shell 
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Figure 1. Structure and topology of HpR1∆136. (A) Crystal packing of HpR1∆136. AB and CD dimers 
are labeled. (B) Cartoon representations of HpR1∆136 in two orientations. Molecules A and B are colored 
green and blue respectively. The asymmetric 7 strand is colored raspberry. (C) Topology diagram of 
HpR1∆136. The core fold of each monomer is shown in blue. The relative position and connectivity of 
the asymmetric 7 strand associated with molecules B and D is denoted by dashed outlines and colored 
in raspberry. The N- and C-arms are colored orange and cyan respectively. (D) 2fo-fc electron density 
(blue mesh) of the 4-7 region in molecule B contoured to 1. (E) Superposition of HpR1∆136 dimers 
AB and CD. AB dimer colored green and blue while CD dimer colored gray. 7 from molecules B and 
D are colored raspberry and gray respectively.  
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Figure 2. Critical structural contacts stabilizing the HpR1∆136 dimer. (A) Zoomed view of 1, 2, and 
7 interactions at the dimer interface. (B) Hydrophobic interactions between 4 helices across the dimer 
interface. (C) SEC-MALS analysis indicates HpR1∆136 exists as a dimer in solution. UV trace (black) 
and calculated molecular weight based on light scattering (blue) are shown. Dashed red lines denote the 
predicted molecular weight of an HpR1∆136 monomer and dimer. 
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Figure 3. SEC-MALS of HpR1136 mutants. V115N is located at the dimer interface (see Fig. 2B) while 
H14A, R17A, P59A, and R60A are putative binding site mutations based on structural homology (See 
Fig. 6D,E). UV trace (black) and calculated molecular weight based on light scattering (blue) are shown. 
Dashed red lines denote the predicted molecular weight of an HpR1∆136 monomer and dimer.  
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Figure 4. HpR1∆136 adopts a B3 fold for site-specific DNA recognition. (A) Superposition of HpR1∆136 
(monomer A, green) with the Arabidopsis thaliana (At) ARF1 B3 domain (monomer A, pink; PDB: 4ldx) 
confirms similar structural fold. (B) Superposition of HpR1∆136 (light blue) with the AtARF1A B3-DNA 
complex (gray; PDB: 4ldx) identifies the N-arm (orange and green) and C-arm (cyan and purple) regions 
that are necessary for target recognition. Structures are oriented looking down the helical axis of bound 
AtARF1 DNA. (C) Electrostatic surfaces of the individual HpR1∆136 and AtARF1 B3 domains. Arrows 
indicate the N- and C-arms. Scale bar indicates electrostatic surface coloring from -3 KbT/ec to +3 KbT/ec. 
(D) Electrostatic surface of the HpR1∆136 AB dimer in two orientations. N- and C-arms are labeled. The 
black circle indicates the location of E131 in molecule B.  
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Figure 5. Structural constraints of B3 domain dimerization. Molecule A (green) and molecule B (blue) 
of HpR1∆136 are shown in each panel with the asymmetric 7 strand (raspberry) and flanking 1 strands 
emphasized to delineate the dimer interface. Coordinates from different B3 domains were superimposed 
with molecule A and the overlapping structural elements that spatially align with the dimer interface are 
labeled and highlighted. PDB codes are indicated for each structure. (A) Superposition with EcoRII 
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(grey). (B) Superposition with BfiI (yellow). (C) Superposition with VRN1 (cyan). (D) Superposition 
with UbaLAI (light blue). (E) Superposition with AtARF1 (pink). (F) Superposition with NgoAVII (light 
orange). (G) Superposition with RAV1 (magenta). (H) Superposition with At1g16640.1 (orange).   
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Figure 6. Structural modeling of HpR1∆136 substrate recognition. (A) Filter binding analysis of 
HpR1∆136 (Hp) and full-length EcMcrB (Ec) interactions with different DNA substrates. Substrates 
abbreviations are as follows: 5mC, methylated EcMcrB-specific substrate; nm, non-methylated  EcMcrB-
specific substrate; Ll, site-specific substrate containing the L. lactis LlaJI.R1 5’-GACGC-3’target site 
sequence; Llscr, substrate with the L. lactis LlaJI.R1 target site sequence scrambled as a control. 
Sequences for each substrate can be found in the Experimental Procedures. Binding was performed at 
30°C for 10 min in a 30 L reaction mixture containing 14.5 nM unlabeled DNA and 0.5 nM labelled 
DNA. Samples were filtered through KOH-treated nitrocellulose and binding was assessed by 
scintillation counting. (B) Relationship between C-arm length and target site length in previously 
determined B3 domain-DNA complexes. (C) Orientation of C-arm loops relative to DNA in various B3 
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domain homologs. DNA from the AtARF1 complex (PDB: 4ldx) is shown. C-arm coloring labeled below 
along with corresponding PDB codes. (D) Key residues in AtARF1 DNA binding. (E) Residues predicted 
to be important for HpR1∆136 DNA binding based on structural comparison. AtARF1 DNA modeled as 
in (D). (F) Filter binding analysis of HpR1∆136 mutants. Point mutations of predicted binding residues 
identified in (D) (H14A, red; R17A, orange; P59A, green; R60A, light blue; R17A/R60A; brown) were 
assessed for binding to the nm DNA substrate. Filter binding was carried out as described in (A). The 
wildtype curve (purple) is the same as shown in (A) (Hp+nm). 
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Figure 7. Electrophoretic mobility shift assay (EMSA) analysis of predicted HpR1136 binding mutants. 
Binding was carried at 25°C for 30 min in a 16 L reaction mixture containing 10 ng/L of digested 
(BamHI/NdeI), non-methylated -phage DNA and increasing concentrations (0-100 M) of each 
HpR1∆136 construct. Gels were stained with SYBR® Green in 1x TAE overnight at 25°C. Calculated 
sizes (bp) of the digested DNA products are noted on the left of each gel. 
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Chapter 3. The crystal structure of the Thermococcus gammatolerans McrB N-
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McrB homologs 
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ABSTRACT 
McrBC is a two-component, modification-dependent restriction system that cleaves 
foreign DNA containing methylated cytosines. Previous crystallographic studies show 
that E. coli McrB uses a base flipping mechanism to recognize these modified substrates 
with high affinity. The sidechains that facilitate DNA binding and stabilize the distorted 
duplex conformation are poorly conserved among McrB homologs, suggesting that 
other mechanisms may exist for binding modified DNA. Here we present the structures 
of the Thermococcus gammatolerans McrB DNA binding domain (Tg∆185) both alone 
and in complex with a methylated DNA substrate at 1.68Å and 2.27Å respectively. 
Tg∆185 consists of a YTH domain, which is commonly found in eukaryotic proteins 
that bind methylated RNA and is structurally unrelated to the E. coli McrB DNA binding 
domain. Structural superposition and co-crystallization identify a conserved aromatic 
cage in Tg∆185 that forms the binding pocket for a flipped-out base. Mutational analysis 
of this aromatic cage supports its role in conferring m6A binding specificity. 
Surprisingly, Tg∆185 binds a single strand along the DNA duplex, which may have 
important functional implications. Together, these data underscore the idea that McrB 
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homologs have evolved different strategies for recognizing modified DNA and suggest 
the overall architecture of McrBC complex is modular, as its highly conserved motor 
and cleavage modules can be retargeted by attaching different DNA binding domains. 
 
INTRODUCTION 
Modification-dependent restriction systems (MDRs) recognize and cleave modified 
DNA (Labrie et al., 2010). Some enzymes like Mrr, McrA, MspJI, and McrBC are 
directed against methylated cytosines (Loenen and Raleigh, 2014) while others like 
GmrSD and members of the PvuRtsI family show specificity toward glucosylated 
nucleic acids (Bair and Black, 2007; Borgaro and Zhu, 2013). Collectively these 
proteins play a role in establishing the epigenetic landscape of bacterial genomes 
(Ishikawa et al., 2010) and are especially important in protecting against predatory 
bacteriophages, many of which incorporate modified bases into their DNA to evade 
detection by other defense systems (Weigele and Raleigh, 2016).  
McrBC is a two-component, motor protein complex that was initially identified 
in E. coli (Ec) genetic screens by its ability to restrict glucosylation-deficient mutants 
of T4 phage (Luria and Human, 1952). EcMcrB is a 53 kDa protein with an N-terminal 
domain (pfam: DUF3578) that binds fully or hemi-methylated RMC recognition 
elements (where R is a purine base and MC is a 4-methyl-, 5-methyl- or 5-
hydroxymethyl-cytosine) (Sutherland et al., 1992; Krüger et al., 1995; Gast et al., 1997; 
Pieper et al., 1999b; Stewart et al., 2000, Zagorskaitė et al., 2018) and a C-terminal 
AAA+ (extended ATPases Associated with various cellular Activities) domain that 
binds/hydrolyzes GTP and mediates nucleotide-dependent oligomerization (Panne et 
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al., 2001). EcMcrB exhibits a low basal GTPase activity (~0.5-1 min-1) that can be 
stimulated ~30-40-fold via interaction with its partner EcMcrC (Pieper et al., 1999b), a 
40 kDa protein that contains a C-terminal PD-(D/E)xK family endonuclease domain 
and lacks the ability to bind DNA on its own (Pieper and Pingoud, 2002). Biochemical 
studies suggest a model for cleavage in which EcMcrB and EcMcrC assemble at two 
RMC sites separated by up to 3 kilobases and translocate DNA in a manner that depends 
on stimulated GTP hydrolysis (Panne et al., 1999). Collision of these assemblies cleaves 
both DNA strands near one of the RMC sites (Stewart et al., 2000; Pieper et al., 2002), 
suggesting the complexes remain bound and translocate via DNA looping or twisting 
(Bourniquel and Bickle, 2002). These mechanochemical properties are reminiscent of 
Type I and Type III restriction-modification systems, which bind DNA at non-modified 
sites separated by up to thousands of base pairs and use ATP hydrolysis to power similar 
long-range translocation events that trigger cleavage either by collision or stalling 
(Dryden et al., 2001).  
EcMcrB achieves specificity through a base flipping mechanism (Sukackaite et 
al., 2012, Zagorskaitė et al., 2018). Modified bases are rotated out of the DNA duplex 
and positioned into a pocket in the N-terminal domain, where they form numerous 
hydrogen bonds and hydrophobic interactions (Supplementary Figure 1). The 
concomitant insertion of a tyrosine residue (Y41) into the resulting gap stabilizes the 
duplex via base stacking. This strategy, while elegant, cannot simply be extrapolated to 
other McrB homologs as their N-terminal domains vary significantly in sequence, size, 
and predicted structural fold across different bacterial and archaeal species (Figure 1). 
In the handful of sequences that show identifiable homology to EcMcrB in this region 
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(e.g. Rhizobium sp. CF097), the tyrosine plug is not conserved and its mutation to the 
corresponding residue at that position – either alanine or glutamine – results in loss of 
DNA binding in vitro (Sukackaite et al., 2012). These findings imply that McrB 
homologs have evolved different mechanisms for substrate binding and/or may 
preferentially target other sequences and modifications. In support of this, we previously 
showed that the N-terminal domain of Helicobacter pylori LlaJI.R1 uses a B3 domain 
to recognize DNA site-specifically (Hosford and Chappie, 2018). 
 Here we present the crystal structures of the N-terminal DNA binding domain 
of Thermococcus gammatolerans McrB (Tg∆185) both alone and in complex with 
methylated DNA at 1.68Å and 2.27Å respectively. Tg∆185 is structurally distinct from 
the EcMcrB DNA binding domain, adopting a YTH domain fold commonly found in 
eukaryotic proteins that bind methylated RNA. Filter binding experiments show that 
Tg∆185 does not bind RNA and instead preferentially associates with 6-methyladenine-
modified (m6A) DNA. The Tg∆185-DNA complex indicates that different specificities 
is a result of an additive effect between the aromatic cage and differences in the 
electrostatic charge distribution compared to other YTH domains. Together these 
findings underscore the notion that McrBC is a modular nuclease that can be adapted to 
a broad array of targets. 
 
RESULTS 
TgMcrB does not preferentially bind m5C DNA 
To understand the broader species-specific determinants of McrB DNA binding, we 
purified both full-length Thermococcus gammatolerans (Tg) McrB and its isolated N-
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terminal domain (Tg∆185, Figure 2A). Tg is a hyperthermophilic, radiation-tolerant 
archaea (Jolivet et al. 2003) and was selected for the enhanced thermostability of its 
proteins. Specificity for DNA containing methylated cytosines is a defining feature of 
EcMcrB (Sutherland et al., 1992; Krüger et al., 1995; Gast et al., 1997; Pieper et al., 
1999b; Stewart et al., 2000, Zagorskaitė et al., 2018). As Tg∆185 share little sequence 
homology with the EcMcrB DNA binding domain (Ec∆155, Figure 2B), we first asked 
whether it could bind m5C modified DNA substrates. Initial characterization by 
analytical size exclusion chromatography (SEC) showed that Tg∆185 forms stable 
complexes similar to Ec∆155 (Figures 2C-D). To assess these interactions 
quantitatively, we examined the retention of radiolabeled m5C and nonmethylated (nm) 
DNA in the presence of full-length TgMcrB or EcMcrB on alkaline-treated 
nitrocellulose filter paper (Papoulas, 1996). Filter binding shows that EcMcrB has a 
strong preference for m5C DNA with a calculated binding constant on the order of ~200 
nM (Figure 2E, Supplementary Table S3). TgMcrB, in contrast, binds both m5C and nm 
DNA almost equally but with weaker affinity (calculated binding constants of ~1-2 M) 
(Figure 2E, Supplementary Table S3). These data indicate TgMcrB is distinct from 
EcMcrB and displays a different sensitivity to modified DNA. 
 
Tg∆185 adopts a YTH domain fold and preferentially binds m6A DNA 
To understand the molecular basis for the observed specificity differences, we 
determined the crystal structure of Tg∆185 at 1.68Å by selenium SAD phasing 
(Hendrickson, 2014) (Figure 3A). Tg185 is comprised of a six-stranded beta sheet – 
ordered 6-1-3-4-5-2 – that is flanked by clusters of -helices (Figure 3B). The 
 93 
stands adopt a mainly antiparallel arrangement with only 1 and 3 oriented in a parallel 
fashion. The extended 4 strand subdivides the sheet and induces a sharp curvature that 
nearly folds the two opposing segments onto one another. Helical segments insert in 
loops that flank the beta sheet: 1 and 2 in the 1-2 loop; 3 and 4 in the 4-5 
loop; 5 and 6 in the 5-6 loop. Importantly, the overall topology of the Tg185 fold 
differs from that of Ec155 (Figure 3C,D). 
The DALI alignment algorithm (Holm and Rosenström, 2010) indicates Tg∆185 
shares structural homology with YTH domains (Z-score 7.5-8.5, RMSD 3.0-3.5) 
(Figure 3E,F). YTH domains are conserved RNA binding modules that specifically 
recognize N6-methyladenosine (m6A) modifications (Zhang et al., 2010, Liu et al., 
2016). In eukaryotes, m6A modifications are linked to the regulation of alternative 
splicing, RNA processing, mRNA degradation, and the circadian clock (Dominissini et 
al., 2012; Schwartz et al., 2013; Fustin et al., 2013, Wang et al., 2014). Given the 
structural similarity to YTH domains and lack of specificity toward m5C DNA, we 
tested whether Tg185 can associate with m6A modified RNA (Figure 4A). Filtering 
binding shows that while the human (Hs) YTHDC1 YTH domain specifically associates 
with m6A RNA (calculated binding constant of 0.5931 M), Tg∆185 shows little 
affinity for either methylated or non-methylated RNA substrates. We next asked 
whether Tg∆185 could bind m6A modified DNA. Surprisingly, Tg∆185 associates more 
tightly with m6A dsDNA, exhibiting a ~6.5-fold increase in affinity compared to m5C 
or non-methylated dsDNA substrates (Figure 4B, Supplementary Table S3). This 
enhancement appears to be driven solely by the modification, as single stranded DNA 
oligos show the same binding profile (Figure 4C). These data indicate that Tg∆185 is a 
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DNA-specific YTH domain that preferentially targets substrates containing m6A 
modifications. 
 
An aromatic cage in Tg∆185 confers specificity for m6A DNA 
Crystallographic studies have shown that YTH domains recognize m6A via a conserved 
“aromatic cage”, wherein two to three aromatic residues provide stabilizing pi-stacking 
and hydrophobic interactions (Li et al., 2014; Luo and Tong, 2014; Theler et al., 2014; 
Zhu et al., 2014; Xu et al., 2014; Xu et al., 2015; Wang et al., 2016). Structural 
superposition with the m6A-bound YTH domain from HsYTHDF2 (PDB ID: 4rdn, Z-
score 8.5, RMSD 3.1) identifies W53, W115, and F121 as putative cage residues in 
Tg∆185, poised to serve as a binding site for modified bases (Figure Supplementary 
Figure S2).  
  To confirm this hypothesis, we determined the crystal structure of Tg∆185 in 
complex with DNA (Figure 5A). Although Tg∆185 crystallized with a variety of 
different modified substrates, suitable diffraction could only be obtained with a 19-mer 
dsDNA substrate that had single base pair overhangs and contained two mismatches 
flanking the internal m5C modifications in each strand (m5C dsDNA mm, Figure 5B). 
Initial maps at 2.64Å revealed defined DNA density associated with each Tg∆185 
monomer and strong peaks for backbone phosphates. Numerous bases throughout the 
duplex, however, remained poorly resolved. An incomplete model for the Tg185-m5C 
dsDNA mm complex was built and used for molecular replacement into a 2.27Å 
resolution isomorphous data set. The higher resolution data set yielded vastly improved 
phases and interpretable electron density for both a stabilized base bound within the 
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aromatic cage and base pairs within the surrounding DNA duplex (Figure 5C-E).  
The asymmetric unit contains a single Tg∆185 monomer bound to a six base 
pairs of DNA (Figure 5C, yellow). These DNA segments pack end-to-end, forming a 
pseudo-continuous duplex throughout the crystal lattice that is highly distorted (Figure 
5F). The significant widening of the major groove (Figure 5F) likely arises from both 
Tg∆185-induced base flipping (Figure 5D) and the presence of mismatches in the DNA 
substrate that enhanced crystallization (Figure 5B). Tg185 decorates the extended 
duplex along a single strand (Figure 5C). This overall organization has two important 
implications. First, it suggests that Tg∆185 can associate with multiple sites along the 
19-mer substrate. Second, it implies that resulting electron density attributed to the DNA 
does not reflect its unique sequence and instead represents an average distribution of the 
bases over the length of the duplex. We modelled the flipped-out bases as adenines since 
they repeat every six bases in the sequence of the crystallized substrate (Figure 5B). 
This yielded the best Rfree value and strongest base density compared to refinement with 
alterative sequence registers. The apo- and DNA-bound Tg185 monomers 
superimpose with an average r.m.s. deviation of 0.549 Å, indicating no significant 
structural changes occur in the protein upon substrate binding.  
 To identify key structural features important in m6A DNA binding, we compared 
Tg185-m5C dsDNA mm to the HsYTHDC1 YTH domain complexed to m6A-ssRNA 
(PDB ID: 4r3i, Z-score 7.7, RMSD 3.3). Like HsYTHDC1, Tg185 contains a large 
basic patch coincident with the aromatic cage to electrostatically interact with nucleic 
acids (Figure 6A,B). The binding and spatial orientation of m6A in the aromatic cage of 
HsYTHDC1 (W377, W428, and I439) is nearly identical to that of Tg185 (Figure 
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6C,D). Although mutagenesis of either tryptophan residues in HsYTHDC1 perturbs 
m6A RNA binding, mutating any of the aromatic cage residues in TgMcrB only reduces 
DNA binding by 7-fold and is comparable to the levels of m5C or nm DNA binding 
(Figure 6E, Supplementary Table S3). No additional loss of binding was gained with a 
triple mutant to alanine. 
Several arginine residues contribute to the basic patch in TgMcrB185 and are 
involved in DNA binding. Residues R55 and R168 form electrostatic interactions with 
the phosphate backbone on opposite strands. Although two arginine residues are shown 
to also engage with RNA in HsYTHDC1, only one is engaged with the phosphate 
backbone (R404) while the other stabilizes the resulting gap due to base flipping (R475) 
and -stacks with the G-1 base. Mutagenesis of R475 in HsYTHDC1 to phenyalanine 
diminishes binding by 9-fold while mutating R475 to alanine decreases binding affinity 
over 100-fold (Xu et al., 2014). Two additional arginine residues in Tg185, R78 and 
R81, engage the DNA bases from the major groove (Supplementary Figure S3C). 
Although R81 could not be modelled due to insufficient electron density, their spatial 
similarity to R475 in HsYTHDC1 made us question their importance in DNA binding. 
However, mutating either R78 or R81 to alanine had no effect on DNA binding 
(Supplementary Figure S3D, Supplementary Table S3). Additional residues that make 
direct contact to DNA in the major groove (Y61 and N82) or form hydrogen bonds to 
the flipped-out adenine base (E16 and N19) also show no decrease in DNA binding 
(Supplementary Figure S3A,B, Supplementary Table S3). Interestingly, a double 
mutant of Y61 and N82 to alanine resulted in a 7-fold increase to DNA binding 
(Supplementary Figure S3D, Supplementary Table S3). 
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DISCUSSION 
Here we described the crystal structures of Tg185 alone and in complex with DNA. 
Tg∆185 adopts a YTH domain fold and shows preference for m6A DNA in vitro. This 
specificity distinguishes Tg∆185 from every other previously characterized YTH 
domain, all of which specifically target modified RNA. Canonical YTH domains use 
base flipping and an aromatic cage to recognize the m6A modification (Li et al., 2014; 
Luo and Tong, 2014; Theler et al., 2014; Zhu et al., 2014; Xu et al., 2014; Xu et al., 
2015; Wang et al., 2016).  Our structural data indicate that Tg∆185 employs the same 
general strategy. Mutation of aromatic cage residues in other YTH domains completely 
abolishes RNA binding (Xu et al., 2014).  Surprisingly, the W53A/W115A/F121A triple 
mutant only reduces Tg∆185’s binding to m6A DNA by ~7-fold, equivalent to its 
affinity for non-methylated DNA. This argues that the aromatic cage alone dictates the 
specificity for the m6A modification while other structural features contribute 
toTg∆185’s overall DNA binding.  
The overall electrostatic surface area of Tg185 varies significantly from 
HsYTHDC1. This is largely due to the varying number of arg residues on the exterior 
surface surrounding the aromatic cage. In the YTH domains that specifically bind RNA, 
such as HsYTHDC1 and HsYTHDF2, only two arg residues are within proximity to 
bind RNA (R404/R475 in HsYTHDC1 and R441/R527 in YTHDF2) (Xu et al., 2014, 
Li et al., 2014). In contrast, Tg185 contains four arg residues in proximity to the bound 
DNA (R55, R78, R81, and R162). Of these, R78 and R81 appear to form base specific 
contacts within the major groove while R55 and R162 form electrostatic, ‘clamp’ 
interactions with the phosphate backbone in opposite strands. We hypothesize that this 
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even distribution of arg residues is a primary driver of the specificity of Tg185 for 
DNA over RNA.  
Additional sequence specific interactions have been identified in other YTH 
domains that are structurally conserved in Tg∆185 (Xu et al., 2014, Li et al., 2014). In 
the YTHDF1 YTH domain structure (PDB ID: 4rcj), residue Y397 wedges between the 
G-1 and m6A bases and confers a preference for binding the sequence Gm6A in RNA. 
The Y61 residue in Tg∆185 is spatially orchestrated similarly to Y397 in YTHDF1 and 
forms a wedge in the major groove with N82. Interestingly, mutagenesis of Y61 and 
N82 to alanine increases Tg∆185s affinity for m6A DNA by nearly 7-fold 
(Supplementary Figure S2, Supplementary Table S3). We hypothesize this may be a 
result of a sequence specific contact that would otherwise be made with an ideal 
substrate. Mutagenesis of Y61 and N82 may therefore increase Tg∆185 binding 
tolerance for. Additional screening of different bases preceding the m6A base 
(specifically at positions -1 and -2) is necessary to validate this observation. 
Canonical McrB as defined in the E. coli homolog has been shown to 
preferentially bind m5C DNA. Therefore, the preference of TgMcrB for m6A over m5C 
was unexpected. We recently published the crystal structure of the N-terminal domain 
of the Helicobacter pylori LlaJI.R1, a site-specific McrB homolog, that revealed it 
recognizes DNA site-specifically via a B3 domain (Hosford and Chappie, 2018). These 
structures reveal different specificities and modes of substrate recognition amongst the 
N-terminal domains of McrB homologs. Interestingly the E. coli McrB has been 
previously shown to contain a cryptic translational start site in the mcrB gene that 
encodes for a shorter version of McrB. This shorter length peptide includes only the 
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motor domain and is thought to play a regulatory role in inhibiting McrBC activity (Dila 
D, 1990). Its GTPase activity is fully functional and can be stimulated by McrC but 
cannot bind or cleave DNA. Taken together, it appears that McrB is a modular 
restriction system that only needs an N-terminal domain to target it to DNA and can be 
used as a platform for the engineering of novel restriction enzymes. 
Because of its specificity for m5C, EcMcrBC is commonly used as a diagnostic 
tool to monitor epigenetic changes underlying mammalian gene expression (Fouse et 
al., 2010), tissue specific development (Santoso et al., 2000), and perturbation to normal 
methylation patterning associated with human diseases like Prader-Willi and Angelman 
syndromes (Chotai and Payne, 1998) and Fragile-X mental retardation (Burman et al., 
1999). Recent studies have implicated N6-methyladenine modification as an important 
epigenetic maker in mammalian cells (Luo and He, 2017, NSMB; Xiao et al. 2018). Our 
structural and biochemical results suggest TgMcrBC could be utilized in a similar 
capacity to track m6A methylation.  
 
EXPERIMENTAL PROCEDURES 
Identification and phylogenetic analysis of McrB homologs 
Putative McrB homologs were initially identified by BLAST using the sequence of the 
E. coli McrB AAA+ domain to search against the DOE Integrated Microbial Genomes 
(IMG/ER) database (Chen et al., 2017). These candidates were only considered if they 
contained the conserved McrB consensus motif MNxxDRS and the presence of an 
adjacent McrC gene could be confirmed by neighbor analysis. Homologs were then 
subdivided into groups according to their divergent N-terminal domains. A phylogenetic 
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tree incorporating a representative from each group was generated using the DOE 
IMG/ER analysis tools. Structural fold prediction for each unique N-terminal domain 
was carried out using the Phyre 2 protein fold recognition server (Kelley et al., 2015). 
 
Cloning, expression, and purification of TgMcrB constructs 
DNA encoding the T. gammatolerans EJ3 McrB protein (DOE IMG ID 644807740) 
was codon optimized for E. coli expression and synthesized commercially by 
GENEART. DNA encoding full-length TgMcrB was amplified by PCR and cloned into 
pET21b, introducing a 6xHis tag at the C-terminus. DNA encoding the N-terminal 
domain (Tg∆185, residues 1-185) was amplified by PCR and cloned into pET15bP, a 
modified pET15b (Novagen) plasmid in which an Hrv3C protease site (LEVLFQGP) 
replaces the thrombin site after the N-terminal 6xHis tag. Native TgMcrB and Tg∆185 
were transformed into BL21(DE3) cells, grown at 37°C in Terrific Broth to an A600 of 
1.0, and then induced with 0.3 mM isopropyl 1-thio--D-galactopyranoside (IPTG) 
overnight at 19°C. All cells were harvested, washed with nickel load buffer (20 mM 
HEPES pH 7.5, 500 mM NaCl, 30 mM imidazole, 5% glycerol (v/v), and 5 mM -
mercaptoethanol), and pelleted a second time. Pellets were flash frozen in liquid 
nitrogen and stored at -80°C. Seleno-methionine labeled (SeMet) Tg∆185 was 
expressed in minimal media in the absence of auxotrophs as described previously (Van 
Duyne et al., 1993). Thawed Pellets from 500-mL cultures were resuspended in 30-ml 
of nickel load buffer supplemented with 10 mM phenylmethylsulfonyl fluoride (PMSF), 
5 mg of DNAse (Roche), 5 mM MgCl2, and a complete protease inhibitor cocktail tablet 
(Roche). Lysozyme was added to 1 mg/ml and the mixture was incubated for 15 min 
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rocking at 4°C.  Cells were disrupted by sonication and the lysate was cleared of debris 
by centrifugation at 13,000 rpm (19,685 × g) for 30 minutes at 4°C. For native and 
SeMet Tg∆185, the supernatant was filtered, loaded onto a 5-ml HiTrap chelating 
column charged with NiSO4 and then washed with nickel load buffer. Tg∆185 was 
eluted with an imidazole gradient from 30mM to 1M. Pooled fractions were dialyzed 
overnight at 4°C into Ni loading buffer with reduced salt (50mM NaCl) in the presence 
of Hrv3C protease to remove the N-terminal His tag. The sample was reapplied to a 5-
ml HiTrap chelating column charged with NiSO4. The flow through was fractionated to 
collect cleaved Tg∆185, concentrated, and further purified by size exclusion 
chromatography (SEC) using a Superdex 75 16/600 pg column. For full-length 
TgMcrB, the supernatant from sonication was filtered, heated to 65°C for 20 min, 
centrifuged at 4,000 rpm (6,057 × g) for 10 min at 4°C, and filtered again prior to 
purification on a 5-ml HiTrap chelating column as described above. Pooled peak 
fractions were concentrated and purified further by SEC. All proteins were exchanged 
into a final buffer of 20mM HEPES pH 7.5, 150mM KCl, 5 mM MgCl2, and 1mM DTT 
during SEC and concentrated to 5-40 mg/ml. SeMet Tg∆185 was purified similarly but 
was supplemented with 5 mM DTT in the SEC buffer. TgMcrB mutants were generated 
by Quikchange mutagenesis (Agilent Technologies) and confirmed by sequencing. 
 
Cloning, expression, and purification of EcMcrB 155 
DNA encoding the full-length E. coli McrB protein (Uniprot P15005; DOE IMG ID 
646316336) was codon optimized for E. coli expression and synthesized commercially 
by GENEART. DNA encoding the N-terminal domain (Ec∆155, residues 1-155) was 
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cloned into pMAL-c2Xp, a modified pMAL-c2X (New England Biolabs) plasmid in 
which an Hrv3C protease site replaces the Factor Xa site after the N-terminal MBP tag. 
Ec155 was transformed into BL21(DE3) cells, grown at 37°C in Terrific Broth to an 
A600 of 1.0, and then induced with 0.3 mM IPTG overnight at 19°C. All cells were 
harvested, washed with TGED500 (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM 
EDTA, 5% glycerol (v/v), and 1 mM DTT), and pelleted a second time. Pellets were 
flash frozen in liquid nitrogen and stored at -80°C. Thawed Pellets from 500-mL 
cultures were resuspended in 30-ml of TGED500 supplemented with 10 mM PMSF, 5 
mg of DNAse (Roche), 5 mM MgCl2, and a complete protease inhibitor cocktail tablet 
(Roche). Lysozyme was added to 1 mg/ml and the mixture was incubated for 15 min 
rocking at 4°C.  Cells were disrupted by sonication and the lysate was cleared of debris 
by centrifugation at 13,000 rpm (19,685 × g) for 30 minutes at 4°C. The supernatant 
was filtered, loaded onto 30-40 ml of amylose resin, washed with TGED500, and eluted 
with TGED500 supplemented with 10 mM D-maltose. Pooled fractions were dialyzed 
overnight at 4°C into TGED with reduced salt (TGED50, 50mM NaCl) in the presence 
of Hrv3C protease to remove the N-terminal MBP tag. The sample was then applied to 
a 5-ml HiTrap Q HP ion exchange column in TGED50 and eluted with a NaCl gradient 
from 50mM to 500mM. Pooled fractions were concentrated and further purified by SEC 
using a Superdex 75 10/300 GL column. Ec155 was exchanged into a final buffer of 
20mM HEPES pH 7.5, 150mM KCl, 5 mM MgCl2, and 1mM DTT during SEC and 
concentrated to 5-40 mg/ml. 
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Cloning, expression, and purification of HsYTHDC1 
DNA encoding the Homo sapiens (Hs)YTHDC1 YTH domain (residues 344-509) was 
codon optimized for E. coli expression and synthesized commercially by Integrated 
DNA Technologies (IDT) and cloned into pET15bP. The HsYTHDC1 344-509 was 
transformed into BL21(DE3) cells, grown at 37°C in Terrific Broth to an A600 of 1.0, 
and then induced with 0.3 mM IPTG overnight at 19°C. All cells were harvested, 
washed with nickel load buffer, and pelleted a second time. Pellets were flash frozen in 
liquid nitrogen and stored at -80°C. Thawed Pellets from 500-mL cultures were 
resuspended in 30-ml of nickel load buffer supplemented with 10 mM PMSF, 5 mg of 
DNAse (Roche), 5 mM MgCl2, and a complete protease inhibitor cocktail tablet 
(Roche). Lysozyme was added to 1 mg/ml and the mixture was incubated for 15 min 
rocking at 4°C.  Cells were disrupted by sonication and the lysate was cleared of debris 
by centrifugation at 13,000 rpm (19,685 × g) for 30 minutes at 4°C. The supernatant 
was filtered, loaded onto a 5-ml HiTrap chelating column charged with NiSO4, washed 
with nickel load buffer, and eluted with an imidazole gradient from 30mM to 1M. 
Pooled fractions were concentrated and further purified by SEC using a Superdex 75 
10/300 GL column. HsYTHDC1 344-509 was exchanged into a final buffer of 20mM 
HEPES pH 7.5, 150mM KCl, 5 mM MgCl2, and 1mM DTT during SEC and 
concentrated to 5-40 mg/ml. 
 
Preparation of oligonucleotide substrates 
All DNA and RNA substrates for analytical SEC, filter binding, and crystallization were 
purchased from IDT. Lyophilized non-methylated and HPLC-purified modified single-
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stranded oligonucleotides were resuspended in to 1 mM in 10 mM Tris-HCl and 1 mM 
EDTA and stored at -20°C until needed. Single-stranded oligonucleotides were 5′ end-
labeled with (γ-32P)ATP using polynucleotide kinase (New England Biolabs) and then 
purified on a P-30 spin column (Bio-Rad) to remove unincorporated label. Duplex 
substrates were prepared by heating equimolar concentrations of complementary strands 
(denoted with suffixes “us” and “ls” indicating upper and lower strands) to 95 °C for 15 
min followed by cooling to room temperature overnight and then purification on an S-
300 spin column (GE Healthcare) to remove ssDNA. Supplementary Table S1 shows 
the sequence of each oligonucleotide used in this work. 
 
Analytical size exclusion chromatography (SEC)  
Samples (50 l) of 100 M EcMcrB 155 or TgMcrB 185 were mixed with m5C 
dsDNA in a 2:1.2 molar ratio in 20 mM HEPES pH7.5, 150 mM KCl, 5 mM MgCl2, 
and 1 mM DTT and incubated at room temperature for 10-15 min. Each reaction was 
fractionated via gel filtration on a Superdex 75 3.2/300 analytical SEC column 
equilibrated with 20 mM HEPES pH7.5, 150 mM KCl, 5 mM MgCl2, and 1 mM DTT. 
Fractions containing samples were subjected to 4-20% gradient SDS-PAGE, silver 
stained for DNA, and Coomassie stained for protein. 
 
Filter binding assays 
The standard buffer for the DNA-binding assays contained 25 mM MES, pH 6.5, 2.0 
mMMgCl2, 0.1 mM DTT, 0.01 mM EDTA, and 40 μg/ml BSA. Binding was performed 
with purified TgMcrB FL (WT or mutants) or HsYTHDC1 3434-509 at 30°C for 10 
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min in a 30-μl reaction mixture containing 14.5 nM unlabeled DNA and 0.5 nM labeled 
DNA. Samples were filtered through KOH-treated nitrocellulose filters (Whatman 
Protran BA 85, 0.45 μM) using a Hoefer FH225V filtration device for ∼1 min. Filters 
were subsequently analyzed by scintillation counting on a 2910TR digital, liquid 
scintillation counter (PerkinElmer Life Sciences). All measured values represent the 
average of at least three independent experiments and were compared with a negative 
control to determine fraction bound. 
 
Crystallization, X-ray data collection, and structure determination 
 SeMet Tg∆185 was crystallized by sitting drop vapor diffusion in 0.1M MES pH6.5, 
3.2M Amm. sulfate with a drop size of 2 L and reservoir volume of 650 l. Crystals 
appeared within 6-8 days at 20°C and were of the space group C2 with unit cell 
dimensions a = 67.84, b = 43.99, c = 61.96 and  = 90.00,  = 120.28,  = 90.00. Samples 
were cryoprotected with Parabar 10312 from Hampton Research and frozen in liquid 
nitrogen. Crystals were screened and optimized at the MacCHESS F1 beamline at 
Cornell University and single-wavelength anomalous diffraction (SAD) data were 
collected remotely on the tuneable NE-CAT 24-ID-C beamline at the Advanced Photon 
Source at the selenium edge energy at 12.663 keV (0.9791 Å) (Table S2). Data were 
integrated and scaled using the NE-CAT RAPD pipeline. Heavy atom sites were located 
using SHELX (Sheldrick, 2008) and phasing, density modification, and initial model 
building was carried out using the Autobuild routines of the PHENIX package (Adams 
et al., 2010). Further model building and refinement was carried out manually in COOT 
(Emsley et al., 2010) and PHENIX respectively (Adams et al., 2010). The final model 
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contained one molecule in the asymmetric unit containing residues 1-175 and was 
refined to 1.68Å resolution with Rwork/Rfree values of 0.1770/0.1907 (Supplementary 
Table S2).  
 SeMet Tg∆185 was crystallized in complex with a 19-mer DNA substrate 
containing a single m5C modification in each strand (meC15 mismatched, 
Supplementary Table S2) by sitting drop vapor diffusion in 0.1M HEPES pH7.5, 20% 
PEG 3350, and 0.20M ammonium sulfate with a drop size of 2 L and reservoir volume 
of 650 l. MeC15 mismatched contained base pair mismatches flanking the m5C sites, 
which were necessary to obtain diffraction quality crystals. Tg∆185 and meC15 
mismatched DNA were mixed at a molar ratio of 2:1.2 and incubated at room 
temperature for 10-15 minutes prior to crystallization experiments. Crystals appeared 
within 10-14 days at 20°C and were of the space group P212121 with unit cell dimensions 
a = 41.87, b = 56.50, c = 109.28 and  = 90.00,  = 90.00,  = 90.00. Samples were 
cryoprotected with Parabar 10312 and frozen in liquid nitrogen. An initial 2.64 Å dataset 
(TgMcrB D185 + meC15 mismatched 1) was collected at NE-CAT 24-ID-E beamline 
at the selenium edge energy at 12.663 keV (0.9791 Å) and solved by molecular 
replacement in PHASER (McCoy et al., 2007) using the unbound Tg∆185 monomer 
structure determined from Se SAD phasing as the search model. A more complete model 
was obtained using the diffraction data from a second crystal, TgMcrB D185 + meC15 
mismatched 2. The structure was solved by molecular replacement with PHASER 
(McCoy et al., 2007) using the MR-derived structure from TgMcrB D185 + meC15 
mismatched 1 as the search model. This vastly improved the resulting maps and 
statistics following subsequent rounds of manual model building and refinement. The 
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final model of crystal 2 contained one molecule in the asymmetric unit containing 
residues 3-175 with 6 bp of the DNA substrate and was refined to 2.27 Å resolution 
with Rwork/Rfree = 0.2455/0.2851 (Supplementary Table S2).  
Structural superpositions were carried out in Chimera (Pettersen et al., 2004). 
All structural renderings were generated using Pymol (Schrodinger) and surface 
electrostatics were calculated using APBS (Jurrus et al., 2018). 
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Figure 1. N-terminal domains of McrB homologs are not conserved. Phylogenetic analysis of 
representative McrB homologs. Conserved C-terminal, GTP-specific AAA+ domains are colored in light 
blue. Divergent N-terminal domains are colored differently according to the predicted fold. The protein 
folds of homologs highlighted in red have been experimentally validated by X-ray crystallography. 
DOE/IMG IDs and applicable PDB codes are as follows: Yersinia pestis sv. Orientalis CO-92 McrB, 
637199492; Acinetobacter baumannii D1279779 McrB, 2563734192; Bacillus cereus 03BB102 McrB, 
643761466; Thermococcus gammatolerans EJ3 McrB, 644807740; Staphylococcus aureus MRSA252 
McrB, 637153557;  Lysinibacillus fusiformis SW-B9 McrB, 2598933124; Firmicutes bacterium JGI 
0000119-P10 McrB, 2519130374; Rhizobium sp. CF097 McrB, 2585392831; Escherichia coli K-12 
MG1655 McrB, 646316336, PDB: 3SSC; Staphylothermus marinus F1, DSM 3639 McrB, 640109242, 
PDB: 6N0S; Lactococcus lactis lactis 1AA59 LlaI.1, 263206860; Lactococcus lactis lactis 1AA59 LlaI.2, 
2632068606; Lactococcus lactis LlaJI.R1, 642916737; Helicobacter pylori LlaJI.R1, 637022177, PDB: 
6C5D. 
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Figure 2. Tg185 binds m5C dsDNA. A,B. Domain architectures of EcMcrB (A) and TgMcrB (B) N-
terminal domains. Ec DNA binding domain is colored orange and Tg N-terminal domain is colored 
yellow. The conserved C-terminal AAA+ domain is colored light blue. Truncated constructs used for 
crystallization and SEC experiments are indicated by the dashed boxes. C. Size shift of Ec155 (upper 
panel) and Ec155 + m5C dsDNA (lower panel) are visualized on SDS-PAGE by change in retention 
volume on SEC. D. Size shift of Tg185 (upper panel) and Tg155 + m5C dsDNA (lower panel) are 
visualized on SDS-PAGE by change in retention volume on SEC. Ec155 and Tg185 are both capable 
of binding the same m5C DNA substrates as indicated by the respective protein bands size shift to an 
earlier retention volume. E. Filter binding analysis of TgMcrB and EcMcrB binding to 5-methylctosine 
modified (m5C) and non-methylated (nm) dsDNA substrates. 
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Figure 3. Tg185 adopts a YTH-fold and varies from the putative Ec155 fold. A, B. Structure (A) 
and topology (B) of Tg185 (yellow). C, D. Structure (C) and topology (D) of Ec155 (orange). E. 
Topology diagram of HsYTHDF2 YTH domain (light blue). F. Structural superposition of Tg185 
(yellow) and the HsYTHDF2 YTH domain (light blue).  
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Figure 4. TgMcrB preferentially binds DNA containing m6A modifications. All data represent the 
average of at least three independent experiments. Calculated Kd values are listed in Supplementary Table 
S3. m5C and m6A denote 5-methylcytosine and 6-methyladenine modifications respectively. nmC and 
nmA denote non-methylated versions of the same substrates. A. Filter binding analysis of TgMcrB and 
HsYTHDC1 YTH domain interactions with RNA substrates. B. Filter binding analysis of TgMcrB 
interactions with double stranded (ds) DNA substrates. Binding curves from Figure 2E are included for 
comparison. C. Filter binding analysis of TgMcrB interaction with different single stranded (ss) DNA 
substrates. D. Filter binding analysis of TgMcrB with different mismatched dsDNA substrates.  
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Figure 5. Structure of Tg185 bound to m5C dsDNA mm. A. Cartoon representation of Tg185 bound 
to m5C dsDNA mm shown in two orientations. Tg185 is colored yellow and bound DNA is colored 
wheat. B. Schematic of the m5C dsDNA mm substrate used for crystallization with Tg185. Mismatched 
bases are colored red and indicated by arrows. C. Crystal packing of Tg185 with m5C dsDNA mm. One 
asymmetric unit is colored yellow with the bound DNA illustrated as sticks and colored wheat. The 
electron density map of the DNA is colored light grey and illustrated as mesh.  D. Zoomed in view of the 
electron density surrounding the flipped-out adenine base. E. Zoomed in view of the electron density 
surrounding base pairs within the bound DNA duplex. F. Structural comparison of m5C dsDNA mm to 
B-form DNA (PDB ID: 1bna) illustrates deformation in the bound DNA. 
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Figure 6. Tg185 utilizes a structurally conserved aromatic cage to bind DNA. A. Electrostatic 
surface of HsYTHDC1 + m6A-ssRNA. B. Electrostatic surface of Tg185 + m6A-dsDNA mm. A yellow 
box is drawn around the aromatic cage and indicated by arrows. Scale bar indicates electrostatic surface 
coloring from −3 KbT/ec to +3 KbT/ec.  C. Zoomed in view of the HsYTHDC1 aromatic cage residues 
(green) and m6A base (wheat). D. Zoomed in view of the Tg185 aromatic cage residues (yellow) and 
modelled adenine base (wheat). E. Filter binding analysis of TgMcrB wild-type and aromatic cage 
mutants with m6A dsDNA. 
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Table S1. DNA and RNA oligonucleotide sequences. 
 
 
m5C 04 us 
5’-CCGGGTAAGA(m5C)CGGTAGCGAGCCCCGAGCGAT 
(m5C)CGGAGAATGGGCC-3’ 
m5C 04 ls 
5’-GGCCCATTCT(m5C)CGGATCGCTCGGGGCTCGCTA 
(m5C)CGGTCTTACCCGG-3’ 
m5C us 5'-AGATCTA(m5C)CGGTAGAGCTT-3' 
m5C ls 5'-TAAGCTCTA(m5C)CGGTAGATC-3' 
nmC us 5'-AGATCTACCGGTAGAGCTT-3' 
nmC ls 5'-TAAGCTCTACCGGTAGATC-3' 
m6A us 5'-AGATCTA(m6A)CGGTAGAGCTT-3' 
m6A ls 5'-TAAGCTCTA(m6A)CGGTAGATC-3' 
nmA us 5'-AGATCTAACGGTAGAGCTT-3' 
nmA ls 5'-TAAGCTCTAACGGTAGATC-3' 
m5C mm us 5’-AGATCTA(m5C)CGGCAGAGCTT-3’ 
m5C mm ls 5'-TAAGCTCTA(m5C)CGGCAGATC-3' 
nmC mm us 5’-AGATCTACCGGCAGAGCTT-3’ 
nmC mm ls 5'-TAAGCTCTACCGGCAGATC-3' 
m6A mm us 5'-AGATCTA(m6A)CGTCAGAGCTT-3' 
m6A mm ls 5'-TAAGCTCTA(m6A)CGTCAGATC-3' 
nmA mm us 5'-AGATCTAACGTCAGAGCTT-3' 
nmA mm ls 5'-TAAGCTCTAACGTCAGATC-3' 
m6A RNA 7mer 5’-CGG(m6A)CUG-3’ 
nmA RNA 7mer 5’-CGGACUG-3’ 
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 Table S2. X-ray Data collection and refinement statistics. 
Data collection 
     Model Tg∆185 Apo 
Tg∆185 + 
meDNA 1 
Tg∆185 + 
meDNA 2 
     PDB code XXXX  XXXX 
     X-ray Source NECAT 24ID-C NECAT 24ID-C NECAT 24ID-E 
     Wavelength (Å) 0.9791 0.9791 0.9791 
     Spacegroup C2 P212121 P212121 
          a, b, c (Å) 67.84, 43.99, 
61.96 
41.87, 56.50, 
109.28 
41.17, 57.30, 
107.51           , ,  (°) 90.00, 120 28, 
90.00 
90.00, 9 .00, 
90.00 
90.00, 9 .00, 
90.00      Resolution (Å)a 53.51 – 1.68 
(1.71 – 
1.68) 
109.28 – 2.64 
(2.77 – 
2.64) 
107.51 – 2.27 
(2.45 – 
2.27) 
     No. measured 
reflectionsa 
214,344 (2,293) 76,849 7, 31) 430,541 64,292) 
     No. unique 
reflectionsa 
17,622 (646  7,972 (895) 17,710 ( ,4 7) 
     Completeness (%)a 97.7 (70.7) 98.0 (85.3) 99.4 (100.0) 
     Multiplicitya 12.2 (3.5) 9.6 (8.6) 24.3 (26.0) 
     Rmeas
a 0.069 (0.127) 0.066 (3.016) 0.082 (1.349) 
     Mean I/σIa 35.0 (7.2) 20.8 (0.6) 18.0 (2.59) 
     CC1/2
a 0.999 (0.987) 0.999 (0.400) 0.999 (0.942) 
Phasing 
     Initial F.O.M    
     No. Se sites    
Refinement 
     Rwork/Rfree 0.1770/0.1907  0.2455/0.2851 
     RMSD    
          Bond lengths 
(Å) 
0.013  0.010 
          Bond angles (°) 1.46  1.28 
     Ramachandran plot    
          Favored (%) 98.27  97.66 
          Allowed (%) 1.73  2.34 
          Outliers (%) 0.00  0.00 
     Average B-Factor 30.42  79.09 
     Clashscore 4.51  8.27 
     No. Atoms    
          Macromolecule    
          DNA    
          Solvent    
a Denotes values for the highest resolution shell 
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 Table S3. Dissociation constants from filter binding experiments 
Construct DNA or RNA Kd (M) 
Error 
(%) 
EcMcrB WT m5C dsDNA 0.1395 0.4747 
EcMcrB WT nmC dsDNA ND* ND* 
TgMcrB WT m5C dsDNA 0.7619 3.0657 
TgMcrB WT nmC dsDNA 0.6299 2.9526 
TgMcrB WT m6A dsDNA 0.1165 2.4366 
TgMcrB WT nmA dsDNA 0.6987 1.0414 
TgMcrB WT m6A RNA 7mer ND* ND* 
TgMcrB WT nm RNA 7mer ND* ND* 
HsYTHDC1 m6A RNA 7mer 0.5931 2.6551 
HsYTHDC1 nm RNA 7mer ND* ND* 
TgMcrB WT m5C dsDNA mm 0.6426 3.3955 
TgMcrB WT nmC dsDNA mm 0.7176 2.6344 
TgMcrB WT m6A dsDNA mm 0.0953 2.4667 
TgMcrB WT nmA dsDNA mm 0.6791 3.7252 
TgMcrB WT m5C ssDNA (US) 1.0117 1.1252 
TgMcrB WT nmC ssDNA (US) 0.8253 0.1404 
TgMcrB WT m6A ssDNA (US) 0.2108 0.6875 
TgMcrB WT nmA ssDNA (US) 1.0424 5.9554 
TgMcrB W53A/W115A m6A dsDNA 1.0341 1.3319 
TgMcrB W53A/F121A m6A dsDNA 0.5496 4.0478 
TgMcrB W115A/F121A m6A dsDNA 0.4449 3.9907 
TgMcrB W53A/W115A/F121A m6A dsDNA 0.7823 5.5741 
TgMcrB E17A/N19A m6A dsDNA 0.0773 1.0464 
TgMcrB Y61A/N82A m6A dsDNA 0.0175 10.939 
TgMcrB R78A/R81A m6A dsDNA 0.0952 0.3428 
*ND – signifies not determined due to incomplete saturation within the data 
acquisition range. 
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Figure S1. EcMcrB recognizes methylated DNA via base flipping. A. Cartoon representation of 
Ec155 (orange) bound to m5C-DNA (light blue) shown in two, perpendicular orientations (PDB: 
3SSC). B. Zoomed in view of the binding pocket in Ec155 that recognizes the flipped out m5C base 
(yellow). Residues contacting the base are labeled along with the inserted tyrosine (Y41) that stabilizes 
the gap in the duplex through base stacking. Dashed black lines indicate hydrogen bonds. 
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Figure S2. Structural superposition of Tg185 with HsYTHDF2. A. Structural superposition of 
Tg185 (yellow) with HsYTHDF2 (light blue) shown in cartoon representation. The m6A base bound to 
HsYTHDF2 is shown in sticks (light blue). B. Zoomed in view of the HsYTHDF2 aromatic cage 
surrounding the bound m6A base (W432, W486, and W491). The aromatic cage residues are 
structurally conserved in Tg185 (W53, W115, F121).  
 
 127 
Figure S3. Additional Tg185-DNA interactions. A. Residues E16 and N19 form electrostatic 
interactions with the modelled adenine base that is flipped out of the DNA duplex into the aromatic 
cage. B. Residues Y61 and N82 form a ‘wedge’ within the major groove. C. R78 and R81 (unmodelled) 
are possible candidates for forming base-specific contacts to DNA. D. Filter binding analysis of 
E16A/N19A, Y61A/N82A, and R78A/R81A double mutants. Binding was carried out using m6A 
dsDNA substrates. All data represent the average of at least three independent experiments. Calculated 
Kd values are listed in Supplementary Table S3. 
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ABSTRACT 
McrBC is a conserved modification-dependent restriction system that in Escherichia 
coli specifically targets foreign DNA containing methylated cytosines. Recent 
crystallographic data show that the N-terminal domain of Escherichia coli McrB binds 
substrates via a base flipping mechanism. This region is poorly conserved among the 
plethora of McrB homologs, suggesting that other species may use alternative binding 
strategies and/or recognize different targets. Here we present the crystal structure of the 
N-terminal domain from Stayphlothermus marinus McrB (Sm3-180) at 2.10Å, which 
adopts a PUA-like EVE fold that is closely related to the YTH and ASCH RNA binding 
domains. Unlike most PUA-like domains, Sm3-180 preferentially binds DNA and can 
associate with different modified substrates. Structural comparison shows that the 
canonical ‘aromatic cage’ binding pocket present in other EVE/YTH domains is 
degenerate in Sm3-180, which may explain its promiscuity in target recognition. 
Mutagenesis and filter binding support this hypothesis. We also identify a specific 
helical insert present in subset of PUA-like domains that correlates with the ability to 
bind DNA. Together these data have important implications for PUA-like domain 
specificity and suggest a broader biological versatility for the McrBC family than 
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previously described. 
 
INTRODUCTION 
Restriction modification systems (RMS) are conserved defense systems that protect 
bacteria against viral bacteriophage (phage) infection (Labrie et al., 2010). Classical 
RMS contain a site-specific DNA binding module, endonuclease core, and associated 
methyltransferase to protect the host genome (Tock and Dryden, 2005). As phages 
incorporated modifications into their genomes to evade RMS, bacteria in turn evolved 
modification-dependent restriction systems (MDRS) – that specifically target and 
cleave methylated and/or glucosylated DNA – to restore the balance in the ongoing arms 
race for survival (Loenen and Raleigh, 2014). These systems define the epigenetic 
landscape of bacterial populations (Ishikawa et al., 2010) and complement CRISPR-Cas 
systems as essential barriers to foreign invaders (Dupuis et al., 2013).  
McrBC is a highly conserved, two-component MDRS consisting of the McrB 
and McrC proteins. Escherichia coli (Ec) McrB contains an N-terminal DNA binding 
domain that recognizes 4-methyl-, 5-methyl-, or 5-hydroxymethylcytosines (Sutherland 
et al., 1992; Krüger et al., 1995; Gast et al., 1997) and a C-terminal AAA+ domain that 
hydrolyzes GTP and facilitates nucleotide-dependent oligomerization (Panne et al., 
2001). EcMcrC contains a C-terminal PD-(D/E)XK nuclease domain but cannot bind 
DNA on its own (Pieper and Pingoud, 2002). To exert its function, EcMcrC associates 
with the EcMcrB oligomer (Pieper and Pingoud), which in vitro stimulates the GTP 
hydrolysis and subsequent DNA translocation (Pieper et al., 1999; Panne et al., 1999). 
Collision of two McrBC complexes is thought to trigger DNA cleavage on both strands 
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near the modified sites (Steward et al., 2000; Pieper et al., 2002). These 
mechanochemical properties are reminiscent of type I and type III RMS, which bind 
DNA at non-modified sites separated by up to thousands of base pairs and use ATP 
hydrolysis to power similar long-range translocation events through which cleavage 
occurs either by collision or stalling (Dryden et al., 2001). Despite this similarity, the 
structural and molecular details of McrBC assembly and translocation remain poorly 
defined and it remains to be seen whether these mechanistic features are conserved in 
other organisms beyond E. coli. 
Recent crystallographic data shows that EcMcrB binds modified DNA via a 
base-flipping mechanism (Sukackaite et al., 2012). The N-terminal domain of EcMcrB, 
however, is poorly conserved among the wide array of McrBC homologs, suggesting 
that other species may use different mechanisms for substrate binding and/or may 
preferentially target other sequences and modifications. This remains a largely 
unexplored area of study. Here we present the crystal structure of the N-terminal domain 
from Stayphlothermus marinus McrB (Sm3-180) at 2.10 Å, which adopts a 
PseudoUridine synthase and Archaeosine transglycosylase (PUA)-like EVE domain 
fold that is prevalent among prokaryotic RNA binding proteins and shares homology 
with eukaryotic YTH/ASCH family proteins. Sm3-180, however, preferentially binds 
DNA and associates with different modified substrates. Structural comparison shows 
that the canonical ‘aromatic cage’ binding pocket found PUA-like domains is 
degenerate in Sm3-180, which may explain its promiscuity in target recognition. 
Mutagenesis and filter binding support this hypothesis. We also identify a specific 
helical insert present in subset of PUA-like domains that correlates with the ability to 
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bind DNA. Together these data have important implications for PUA-like domain 
specificity and suggest new mechanistic possibilities for McrBC enzymes, underscoring 
the modular nature of these nuclease complexes. 
 
RESULTS 
SmMcrB 3-180 adopts an EVE domain fold 
Previous biochemical and structural studies established that the EcMcrB N-terminal 
domain (residues 1-155) recognizes DNA containing methylated cytosines (5mC) 
(Sutherland et al., 1992; Krüger et al., 1995; Gast et al., 1997) via a base flipping 
mechanism (Sukackaite et al., 2012). This domain, however, is only conserved in a 
handful of McrB homologs (Sukackaite et al., 2012), suggesting other species use 
different strategies for substrate binding and/or may preferentially target other 
sequences and modifications. To test this hypothesis and explore the evolutionary 
diversity of this family, we screened divergent McrB homologs containing unique N-
terminal sequences and identified the N-terminal domain from Staphylothermus 
marinus McrB (Sm3-180; Figure 1A) as a suitable candidate for structural and 
biochemical characterization. This construct is thermally stable, could be expressed in 
E. coli and purified to homogeneity in milligram quantities, and readily crystallized by 
sitting drop vapor diffusion. The C-terminal AAA+ domain of SmMcrB and the 
accompanying SmMcrC nuclease share identifiable homology with their E. coli counter 
parts (Figure 1A), suggesting that only the putative substrate binding module is distinct 
in this species while the motor and cleavage machinery remain unaltered. Recombinant 
selenomethionine-labeled Sm3-180 yielded crystals of the space group P43212 with 1 
 133 
molecule in the asymmetric unit. The structure was solved by single wavelength 
anomalous diffraction (SAD) phasing (Hendrickson, 2014) and the final model was 
refined to 2.10Å resolution with Rwork and Rfree values of 0.1880 and 0.2298 (Table 1). 
Sm3-180 is composed of a central six-stranded pseudobarrel, connected with an 
intricate network of extended loops and -helical inserts (Figure 1B). The strands are 
ordered 6-1-3-4-5-2 with each oriented in an antiparallel configuration except 1 and 
3, which are parallel (Figure 1B). Helix 1 lies between 2-3 while helices 2 and 
3 are inserted in tandem between 4-5 (Figure 1C). A fourth helix, 4, follows 6 at 
the C-terminal end of the domain (Figure 1C). Attempts to superimpose Sm3-180 with 
N-terminal DNA binding domain of EcMcrB (PDB: 3SSD) failed to yield a consistent 
structural alignment, suggesting their structural topologies differ significantly. A 
homology search via the Dali server (Holm and Rosenström, 2010) supports this 
presumption and instead classifies Sm3-180 as an EVE domain fold. EVE domains are 
part of a larger superfamily of PUA-like domains that also include YTH and ASCH 
folds (Bertonati et al., 2009). These domains all share a core five-stranded pseudobarrel 
architecture and function as RNA recognition modules in bacterial, archaeal, and 
eukaryotic proteins (Iyer et al., 2006; Perez-Arellano, 2007; Bertonati, et al. 2009). 
Although many PUA-like domains also contain various inserts spaced throughout the 
core fold, EVE and YTH domains contain a sixth -strand and are more closely related 
despite low sequence identity (Bertonati, et al. 2009). Structural superposition of Sm3-
180 with three of the top Dali hits confirms structural similarity with PUA-like domain 
containing proteins: the PSPTO5229 EVE domain (PDB: 2eve, Z-score = 9.8, RMSD 
= 2.9Å), the Zymomonas mobilis (Zm) ASCH domain (PDB: 5y6c, Z-score = 10.9, 
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RMSD = 2.6Å), and YTHDC1 YTH domain (PDB: 4r3i, Z-score = 9.1, RMSD = 2.6Å) 
(Figure 2A). A structure-based sequence alignment further shows that Sm3-180 
contains all the residues characteristic of prokaryotic EVE domains, distinguishing it 
from eukaryotic YTH domains (Figure 2B). 
 
SmMcrB preferentially binds DNA 
PUA-like domains bind RNA and contain a swath of positively charged residues on one 
face that forms a cleft for the negatively charged RNA phosphate backbone (Figure 3A). 
Two sulfate ions co-crystallized with Sm3-180, which are bound in this cleft and 
localized along the positively charged electrostatic surface (Figure 3A). Of all 
previously identified PUA-domains, only YTH domains have been extensively studied 
and specifically associate with short RNAs containing 6-methyladenine (m6A), with 
G(m6A)C serving as the primary consensus site (Xu et al., 2015). EVE domains remain 
largely uncharacterized and minimal biochemical data exists supporting their RNA 
binding capacity. To determine whether SmMcrB shares this RNA binding activity, we 
analyzed Sm3-180’s association with methylated RNA oligonucleotides via filter 
binding (Fig. 3B, Supplementary Table 1). In contrast to YTH domains (Luo and Tang, 
2014; Xu, et al., 2014; Theler, et al., 2014; Xu, et al., 2015), Sm3-180 shows only weak 
affinity for m6A RNA (Fig. 3B, cyan and purple). Recent structural studies 
demonstrated that a putative Zymomonas mobilis ASCH protein (ZmASCH) can bind 
DNA as well as RNA (Kim et al., 2017). We therefore tested whether Sm3-180 could 
interact with methylated (m6A or m5C) and/or non-methylated DNA substrates 
(Supplementary Table 1). Sm3-180 binds DNA with much stronger affinity and does 
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not discriminate between different modifications (Fig. 3B, black, red, and blue). We 
also note that Sm3-180 binds single stranded m6A DNA with nearly the same affinity 
as the double stranded substrates (Figure 3B). These data argue that Sm3-180 is an EVE 
domain that preferentially binds DNA. 
 
SmMcrB contains a degenerate aromatic cage and large 4-5 insert 
Given that all other PUA-like domains show a strong preference for RNA, we examined 
the available structural models in greater detail to identify topological features that could 
explain Sm3-180’s unique substrate binding profile. A key defining feature of all PUA-
like domains is the presence of a conserved hydrophobic pocket – colloquially termed 
the ‘aromatic cage’ – that sits at the base of the positively charged cleft (Figure 3A, 
yellow circles). Structural characterization of YTH domain-RNA complexes (Luo and 
Tang, 2014; Xu et al., 2014; Theler et al., 2014; Xu et al., 2015) has shown that the 
aromatic cage is critical for substrate binding and discrimination, stabilizing the m6A 
base through a combination of hydrophobic interactions and - stacking (Figure 4A). 
In the human YTHDC1 YTH domain, W377 in 2 and W428 and L439 in the 4-5 
loop form the cage (Figure 4A, 5A). This canonical arrangement is also observed in the 
PSPTO5229 EVE domain structure with F13 from 1-1 loop, W25 from 2-3 loop, 
and Y82 from 4-5 loop occupying similar spatial positions (Figure 4B, 5A). Sm3-
180 and ZmASCH both contain a helical insert (2-3) within the 4-5 loop that is 
absent in PSPTO5229 and YTHDC1 (Figure 5B). These inserts alter the overall shape 
and organization of the aromatic cage, causing them to deviate from the canonical 
arrangement. In ZmASCH, W15 from the 1-1 loop,  F18 from 1, and Y90 from 3 
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in the 4-5 insertion form the cage (Figure 4C, 5A). Structural superposition aligns 
W31 and Y164 in Sm3-180 with W428 and W377 from YTHDC1 (Figure 4D). 
SmMcrB lacks an analogous side chain at the position of L439 and instead appears to 
utilize I123 from 3 to close the binding pocket from the opposite side (Figure 4D). A 
triple mutant of W31A/I123A/W164A retains dsDNA binding capacity albeit at a 
reduced level (Figure 4E), suggesting the Sm3-180 aromatic cage is degenerate and that 
other structural motifs may contribute to substrate recognition. 
 
DISCUSSION 
Here we showed that the N-terminal domain of SmMcrB is an EVE domain. Although 
EVE domains are distinct among PUA-like domains, the overall topological similarities 
to YTH and ASCH domains allow for structural and functional comparisons. YTH 
domains preferentially bind m6A modified RNA, with the conserved aromatic cage 
residues serving as the sole determinants of substrate recognition and discrimination 
(Luo and Tang, 2014; Xu et al., 2014; Theler et al., 2014; Xu et al., 2015). Our data 
shows Sm3-180 preferentially binds DNA (Figure 3B). Structural superposition reveals 
that the Sm3-180 aromatic cage is degenerate and deviates from the canonical 
arrangement seen in other EVE and YTH domains (Figure 4). Mutation of the aromatic 
cage in Sm3-180 only partially inhibits DNA binding (Figure 4E), suggesting an 
alternate mode of substrate recognition is utilized.  
Sm3-180 has a large helical insert in the 4-5 loop (Figure 5), which changes 
the organization of the aromatic cage and may provide additional motifs that confer 
specificity for DNA. Consistent with this hypothesis is the observation that ZmASCH 
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also contains a helical insert (Figure 5B) and can bind both DNA and RNA (Kim et al., 
2017). The ZmASCH aromatic cage similarly deviates from the canonical arrangement, 
with two of the three hydrophobic residues localizing to the opposite side of the central 
-sheet (Figure 5A). Moreover, the recently deposited structure of the human THYN1 
protein in complex with m5C DNA reveals an EVE domain with a similar helical insert 
in the 4-5 loop (PDB: 5j3e). THYN1 primarily interacts with DNA via various polar 
and charged residues on the basic patch with the insert reaches around to contact 
phosphate backbone. The presence of a 4-5 loop insert thus appears to correlate with 
the ability to bind DNA and may serve as an important predictive feature when 
characterizing new PUA domain-containing proteins. 
 Sm3-180 constitutes the substrate binding domain of Staphylothermus marinus 
McrB. Despite its preference for DNA, Sm3-180 displays promiscuity with regard to 
binding modifications (Figure 3B). This is in stark contrast to the N-terminal domain of 
E. coli McrB, which strictly recognizes DNA containing methylated cytosines 
(Sutherland et al., 1992; Krüger et al., 1995; Gast et al., 1997). These differences may 
reflect distinct evolutionary pressures, such as attack by lytic bacteriophages with 
different genomic content and modifications (Weigele and Raleigh, 2016). Distantly 
related McrB homologs like LlaJI, LlaI, and BsuMI target DNA site-specifically – a 
direct consequence of the unmodified viruses they provide protection against 
(O’Sullivan et al., 1995; Ohshima et al., 2002; O’Driscoll et al., 2006). We recently 
showed that N-terminal domain of LlaJI.R1 from Helicobacter pylori adopts a B3 
domain fold to recognize DNA independent of modifications (Hosford and Chappie, 
2018). Collectively these observations suggest an emerging theme in which bacteria 
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have adapted a conserved set of core machinery – the GTP-specific AAA+ motor of 
McrB and the associated McrC nuclease – to different biological contexts through the 
incorporation of alternative N-terminal binding domains. Although EcMcrBC is 
historically described as a prototypical MDRS (Loenen and Raleigh, 2014), it appears 
members of the McrBC superfamily can be classified more broadly as modular 
nucleases and can be tuned for different substrates.  
 
EXPERIMENTAL PROCEDURES 
Cloning, expression and purification SmMcrB 3-180 constructs 
DNA encoding the Staphylothermus marinus F1 McrB protein (DOE IMG/M ID 
640109242; Chen et al., 2017) was codon optimized for E. coli expression and 
synthesized commercially by Integrated DNA Technologies (IDT), Inc. DNA encoding 
the N-terminal domain (Sm3-180) was amplified by PCR and cloned into pCAV4, a 
modified T7 expression vector that introduced an N-terminal 6xHis-NusA tag followed 
by a Hrv3C protease site upstream of the inserted sequence. Seleno-methionine labeled 
(SeMet) Sm3-180 was transformed into BL21(DE3) cells, grown at 37°C in minimal 
media, and expressed in the absence of auxotrophs as described previously (Van Duyne 
et al., 1993).  Native Sm3-180 was transformed into BL21(DE3) cells, grown at 37°C 
in Terrific Broth to an OD600 of 1.0, and then induced with 0.3 mM IPTG overnight at 
19°C. All cells were harvested, washed with nickel load buffer (20 mM HEPES pH 7.5, 
500 mM NaCl, 30 mM imidazole, 5% glycerol (v:v), and 5 mM -mercaptoethanol), 
and pelleted a second time. Pellets were typically flash frozen in liquid nitrogen and 
stored at -80°C.Thawed pellets from 500 ml cultures were resuspended in 30 ml of 
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nickel load buffer supplemented with 10 mM PMSF, 5 mg DNAse I (Roche), 1 mM 
MgCl2, and a complete protease inhibitor cocktail tablet (Roche). Lysozyme was added 
to 1 mg/ml and the mixture was incubated for 15 minutes rocking at 4°C.  Cells were 
disrupted by sonication and the lysate was cleared of debris by centrifugation at 13 000 
rpm (19 685 g) for 30 minutes at 4°C. For native and SeMet Sm3-180, the supernatant 
was filtered, loaded onto a 5 ml HiTrap chelating column charged with NiSO4 and then 
washed with nickel load buffer. Sm3-180 was eluted with an imidazole gradient from 
30 mM to 1 M. Hrv3C protease was added to pooled fractions and dialyzed overnight 
at 4°C into SP loading buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM EDTA, 5% 
glycerol (v:v), and 5 mM DTT). The sample was applied to a 5 ml HiTrap SP HP column 
equilibrated with SP loading buffer and then washed with SP loading buffer. Sm3-180 
was eluted with a NaCl gradient from 50 mM to 1 M. Pooled fractions were subjected 
to a 30 kDa Millipore centrifugal concentrator, flow through collected, and concentrated 
on a 10 kDa centrifugal concentrator. The concentrated protein was further purified by 
size exclusion chromatography (SEC) using a Superdex 75 10/30 pg column. All 
proteins were exchanged into a final buffer of 20 mM HEPES pH 7.5, 150 mM KCl, 5 
mM MgCl2, and 1 mM DTT (5 mM for SeMet labelled) during SEC and concentrated 
to 5-40 mg/ml. Concentrations of purified proteins were determined by SDS-PAGE 
with BSA standards. All point mutations were introduced into Sm3-180 in pCAV4 by 
quick change PCR and proteins purified as described previously. 
 
Crystallization, X-ray data collection, and structure determination 
SeMet Sm3-180 was crystallized by sitting drop vapor diffusion in 0.1 M BisTris 
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Propane pH 7.5, 0.2 M Na2SO4, and 23% PEG3350 with a drop size of 2 L and 
reservoir volume of 65 L. The reservoir was supplemented with 5 mM DTT 
immediately prior to setting up the drop. Crystals typically appeared within 2-8 days at 
20°C and were cryoprotected with Parabar 10312 and frozen in liquid nitrogen. They 
were of the space group P43212 with unit cell dimensions a = 62.41 Å, b = 62.41 Å, c = 
118.63 Å and  = 90.00°,  = 90.00°,  = 90.00°. Single-wavelength anomalous 
diffraction (SAD) data were collected remotely on the tuneable NE-CAT 24-ID-C 
beamline at the Advanced Photon Source at the selenium edge energy at 12.663 kEv 
(Table 1).  Data were integrated and scaled using XDS (Kabsch, 2010) and AIMLESS 
(Evans, 2006) via the NE-CAT RAPD pipeline. Heavy atom sites were located using 
SHELX (Sheldrick, 2008) and phasing, density modification, and initial model building 
was carried out using the Autobuild routines of the PHENIX package (Adams et al., 
2010). Further model building and refinement was carried out manually in COOT 
(Emsley et al., 2010) and PHENIX (Adams et al., 2010) respectively. The final model 
was refined to 2.10Å resolution with Rwork/Rfree = 0.1880/0.2298 (Table 1) and 
contained one molecule in the asymmetric unit: chain A, 3-180. All structural models 
were rendered with Pymol (http://www.pymol.org) and surface electrostatics were 
calculated with APBS (Jurrus et al., 2018). 
 
Preparation of oligonucleotide substrates 
DNA (Integrated DNA technologies, IDT) and RNA (Dharmacon) for filter binding 
were synthesized commercially as lyophilized, single-stranded oligonucleotides. All 
oligonucleotides were resuspended to 1 mM in 10 mM Tris-HCl and 1 mM EDTA and 
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stored at -20°C until needed. Single-stranded oligonucleotides were 5’ end-labeled with 
(32P)ATP using polynucleotide kinase (New England Biolabs) and then purified on a 
P-30 spin column (BioRad) to remove unincorporated label. Duplex substrates were 
prepared by heating equimolar concentrations of complementary strands to 95°C for 15 
minutes followed by cooling to room temperature overnight and then purification on an 
S-300 spin column (GE) to remove single stranded DNA. Three duplex substrates – 
5mC dsDNA (5mC DNA US and 5mC DNA LS), m6A dsDNA (m6A DNA US and 
m6A DNA LS), and nm dsDNA (nm DNA US and nm DNA LS) – were prepared. Three 
single-stranded substrates – m6A ssRNA 5mer, m6A ssRNA 7mer, and m6A ssDNA US 
– were left untreated and used accordingly. See Supplementary Table 1 for 
oligonucleotide sequences. 
 
Filter binding assays 
The standard buffer for the DNA and RNA binding assays contained 25 mM MES (pH 
6.5), 2.0 mM MgCl2, 0.1 mM DTT, 0.01 mM EDTA, and 40 g/mL BSA. Binding was 
performed with purified SmMcrB 3-180 or mutants at 30°C for 10 min in a 30 L 
reaction mixture containing 14.5 nM unlabeled DNA and 0.5 nM 32P-labelled DNA. 
Samples were filtered through KOH-treated nitrocellulose filters (Whatman Protran BA 
85, 0.45 M) using a Hoefer FH225V filtration device for approximately 1 min.  Filters 
were subsequently analyzed by scintillation counting on a 2910TR digital, liquid 
scintillation counter (PerkinElmer). All samples were measured in triplicate, averaged, 
and compared to a negative control to determine fraction bound. 
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Accession numbers 
The atomic coordinates and structure factors for the N-terminal domain of 
Staphylothermus marinus McrB (residues 3-180) has been deposited in the Protein Data 
Bank (http://www.rcsb.org) under the PDB code 6N0S. 
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Table 1. X-ray data collection and refinement statistics for SmMcrB 3-180 
Data collection 
     PDB code 6N0S 
     X-ray Source NECAT 24-ID-C 
     Wavelength (Å) 0.9791 
     Space group P43212 
     Unit cell a = 62.41, b = 62.41, c = 118.63 Å 
 = 90.00°,  = 90.00°,  = 90.00° 
     Resolution, Åa 55.26 – 2.10 (2.34 – 2.10) 
     No. measured reflectionsa 1297122 (171896) 
     No. unique reflectionsa 61793 (7394) 
     Completeness (%)a 99.9 (100.0) 
     Multiplicitya 42.2 (23.2) 
     Rmerge
a 0.113 (0.429) 
     Mean I/σIa 12.6 (8.22) 
     CC1/2
a 0.999 (0.993) 
Refinement 
     Rwork/Rfree 0.1880 / 0.2298 
     RMSD  
          Bond lengths (Å) 0.013 
          Bond angles (°) 1.021 
     Ramachandran plot  
          Favored (%) 96.09 
          Allowed (%) 3.91 
          Outliers (%) 0.00 
     Average B-Factor 45.04 
     Clashscore 4.23 
     No. Atoms  
          Macromolecule 1522 
          Solvent 94 
          Sulfate 10 
a Parentheses indicate values for highest resolution shell 
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Figure 1. Structure and topology of Sm3-180.  
A. Domain architecture of SmMcrBC. Dashed line denotes crystallized construct (residues 3-180). B. 
Cartoon representations of SmMcrB 3-180 in two orientations. Helices and -strands are colored 
raspberry and blue respectively. C. Topology diagram of SmMcrB 3-180.  
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Figure 2. Sm3-180 adopts an EVE domain fold. 
A. Structural superpositions of SmMcrB 3-180 with PSPTO5229 (PDB: 2eve, Z-score = 9.8, RMSD = 
2.9Å), ZmASCH (PDB: 5y6c, Z-score = 10.9, RMSD = 2.6Å), and YTHDC1 YTH (PDB: 4r3i, Z-score 
= 9.1, RMSD = 2.6Å). B. Structure based sequence alignment of SmMcrB 3-180 with EVE domain 
homologs. Secondary structure of SmMcrB 3-180 is mapped above alignment. Conserved residues that 
distinguish EVE domains from YTH domains are present in SmMcrB 3-180 and colored red. Sequence 
labeling associated with the listed PDB codes is as follows: 2HD9:A, PH1033 from Pyrococcus horikoshii 
OT3; 2P5D:A, MJECL36 from Methanocaldococcus jannaschii DSM 2661; 2GBS:A, Rpa0253 from 
Rhodopseudomonas palustris; 1ZCE:A,  Atu2648 from Agrobacterium tumefaciens; 2AR1:A, 
Hypothetical protein from Leishmania major; 2EVE:A, PSPTO5229 from Pseudomonas syringae; 
2G2X:A, Q88CH6 from Pseudomonas putida. 
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Figure 3. SmMcrB preferentially binds DNA and is promiscuous.  
A. Electrostatic surfaces of SmMcrB 3-180, PSPTO5229 (PDB: 2eve), ZmASCH (PDB: 5y6c), and 
YTHDC1 YTH domain with bound 5’-GG(m6A)CU-3’ ssRNA (PDB: 4r3i). Bound sulfate ions and RNA 
are shown in stick representation and colored yellow and wheat respectively. Yellow circle shows location 
of the aromatic cage binding pocket. Scale bar indicates electrostatic surface coloring from -3 KbT/ec to 
+3 KbT/ec. B. Filter binding of SmMcrB 3-180 with DNA and RNA shows preference for DNA. 
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Figure 4. SmMcrB contains a degenerate aromatic cage.  
A. Zoomed view of aromatic cage from YTHDC1 with bound m6A (PDB: 4r3i). Cage residues are 
highlighted with surface dots and labeled. m6A base from bound RNA is shown (wheat). Calculated 
interaction distances are indicated. B. Zoomed view of PSPTO5229 aromatic cage  (light orange; PDB: 
2eve). C. Zoomed view of ZmASCH aromatic cage (light blue, PDB: 5y6c). D. Superposition of RNA-
bound YTHDC1 YTH (light green) with SmMcrB 3-180 (dark blue). Cage residues from each structure 
are shown as sticks and labeled. m6A base from RNA substrate is colored wheat. E. Filter binding of 
SmMcrB 3-180 WT with m6A dsDNA (red) and W31A/I123A/W164A triple mutant with m6A dsDNA 
(green), 5mC dsDNA (orange), and non-methylated (nm) dsDNA (brown). 
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Figure 5. Organization of structural motifs dictating binding specificity in PUA-like domains. 
A. Topology diagrams of the of PUA-like domains. Structural core is colored gray with respective 4-5 
loops and inserts are colored as follows: SmMcrB 3-180, dark blue; PSPTO5229, light orange; ZmASCH, 
light blue; YTHDC1, light green. Relative positions of aromatic cage residues are marked with black 
circles and labeled. B. Structural superposition of PUA like domains highlighting differences in the 4-
5 loop. Structural motifs colored as in A. 
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Chapter 5. Concluding Remarks and Future Directions 
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Concluding Remarks 
My work described here aims to redefine the modification dependent restriction system, 
McrBC. McrBC has historically been identified as a modified cytosine restriction 
system. Bioinformatic analysis coupled with structural studies performed here show that 
not only are the N-terminal DNA binding modules highly divergent amongst McrB 
homologs, but that they have evolved to have varying target specificities and modalities 
of recognition. For instance, the Helicobacter pylori LlajI.R1 N-terminal domain adopts 
a B3 domain for site-specific recognition, the Thermococcus gammatolerans McrB N-
terminal domain adopts a YTH domain for m6A DNA recognition, and the 
Staphylothermus marinus McrB N-terminal domain adopts an EVE domain for 
nonspecific DNA recognition.  
Interestingly, the remainder of the McrBC system is highly conserved, including 
the McrB C-terminal GTP-specific AAA+ and the McrC PD-(D/E)XK endonuclease. 
In fact, in E. coli, the C-terminal domain alone is capable of reconstituting stimulated 
GTP hydrolysis and the only thing preventing it from being functional on DNA is the 
lack of a DNA binding module. McrBC therefore seems to be a highly modular 
restriction system that has incorporated different N-terminal domains to target the 
system to varying sites. The selective pressure behind this evolution is presumably to 
protect itself from phages with different signatures to escape restriction. This unique 
modularity provides a potential platform for the engineering of novel restriction 
enzymes with potentially limitless recognition sites.  
 
  
 156 
Future Directions 
Although my work has aimed to redefine the McrBC system as a modular restriction 
enzyme with a broad scope of targets, many other McrB homologs with varying N-
terminal domains still exist. Furthermore, many questions regarding its mechanism of 
action in GTP binding, stimulated hydrolysis, and cleavage remain. A crystal structure 
of the AAA+ domain from an McrB homolog, LlaI.2, solved in our lab is the first 
stepping stone to answering some of these more complex questions. The structure is 
briefly described in Appendix 1 and revealed some surprising results. These 
observations are corroborated by the crystal structure of the TgMcrB AAA+ domain 
also solved by our lab (not discussed here). Together these structures have identified 
key catalytic residues involved in GTP binding and GTP hydrolysis. The table below 
lists some of these residues that are potential targets for mutagenesis in our functional 
assays. Structural conservation between LlaI.2 and TgMcrB AAA+ allowed us to also 
identify the analogous residues in EcMcrB. 
Although simple GTP hydrolysis/stimulation experiments of these mutants 
would prove useful, two additional key experiments would provide the necessary 
information to put structure and function in the context of bacterial defense and phage 
restriction. These are 1) in vivo phage competition assays with wild-type and mutant 
McrBC systems and 2) in vitro cleavage assay with substrates varying in m5C spacing. 
The in vivo results (coupled with in vitro GTP hydrolysis) would irrefutably allow us to 
argue the residues observed in our structure are responsible for stimulated GTP 
hydrolysis. These would be measured by cell viability in the presence and absence of 
phage harboring m5C DNA. The in vitro cleavage assay would allow us to measure the 
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dependence of stimulated GTP hydrolysis on translocation of McrBC. In an ideally 
spaced substrate of 40-60 bp, McrBC should be functional in GTPase dead mutants as 
translocation is not necessary. Likewise, in a long-ranged substrate (100-2000 bp), 
McrBC should not be functional in a GTPase dead mutant as translocation is necessary. 
  The final key experiment necessary to bring this project full circle is to solve 
the crystal or cryo-EM structure of the full-length McrBC complex + DNA. It cannot 
be understated the value of an atomic resolution structure of this assembly, especially if 
captured in a cleavage competent conformation. This structure would aim to reveal 1) 
the organization of the DNA binding domains around the McrB oligomer, 2) the 
interaction of McrB with McrC, and 3) the organization of DNA on the complex, 
particularly at the DNA binding sites and the endonuclease active site.   
TgMcrB EcMcrB Function position 
K221 K207 Walker A p-loop cis 
T222 T208 Mg2+ binding cis 
W223 F209 guanine binding cis 
D356 D279 Walker B, mg2+ binding cis 
E357 E280 Walker B, mg2+ binding cis 
E375 E298 ribose interacting trans 
D377 D300 ribose, ab-phosphate interacting trans 
N410 N333 g4 MNTAD, positions catalytic water cis 
D413 D336 g4 MNTAD, positions N410 (N333) cis 
D420 D343 positions D413 (D336) trans 
R425 R348 Arg from sensor 2 trans 
R426 R349 Arg finger trans 
H501 H407 guanine binding cis 
    
TgMcrC EcMcrC Function position 
R263 K157 positions D413 (D336)  
 D244 Mg2+ binding  
 D257 Mg2+ binding  
 K259 charge compensation  
 
 158 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1. Crystal Structure of LlaI.2 
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McrBC is a two-component modification dependent restriction that includes the 
McrB and McrC proteins. McrB is a two-domain protein with an N-terminal putative 
DNA binding domain and a C-terminal GTP-specific AAA+ domain. McrC is also a 
two domain protein with an N-terminal DUF and a C-terminal PD-(D/E)XK 
endonuclease domain. Previous studies show that McrB undergoes GTP-dependent 
oligomerization and has a low basal level of GTP hydrolysis that is stimulated by the 
presence of McrC (Pieper et al., 1997 and 1999). To understand how this unique AAA+ 
domain is capable of binding and hydrolyzing GTP, we have solved the crystal structure 
of an McrB homolog, LlaI.2, in the presence of GDP-AlFx to 1.92 Å. LlaI.2 is part of 
the LlaI restriction/modification cassette in Lactococcus lactis. This cassette encodes 
for four proteins, M1 – a methyltransferase, R1 – a putative DNA binding domain, R2 
– a GTP specific AAA+, and R3 – a PD-(D/E)XK endonuclease. The fact that LlaI.2 
exists as its own independent AAA+ was a deciding factor in choosing it as a potential 
crystallization target. 
 
KEY RESULTS AND DISCUSSION 
Crystals of LlaI.2 were grown in the presence of the GTP transition state mimic, GDP-
AlFx, and data was collected at the NE-CAT 24-ID-C beamline (Figure 1). The crystal 
structure of LlaI.2 reveals that it oligomerizes as a hexamer in the space group H3 
(Figure 2). Although there are only two molecules in the asymmetric unit, multiple 
symmetry related molecules were used to create the full hexamer. A recent study on the 
E. coli McrB revealed that it also oligomerizes as a hexamer in the presence of GTP and 
suggests this organization may be conserved across McrB homologs (Nirwan, et al., 
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2019). 
GDP was bound in every other molecule within the hexameric arrangement with 
a citrate from the crystallization condition bound in every adjacent molecule (Figure 2). 
Inspection of the GDP bound molecules revealed that guanine base recognition is 
achieved via -stacking with F235 from above the indole plane and R17 from below. 
An additional glutamine Q174 hydrogens bonds with the carbonyl at the 6 position of 
the guanine base. The R17 residue immediately succeeds the P-loop and an aromatic 
residue is conserved in this position for all McrB homologs (Figure 4). This mode of 
GTP binding is unique among all GTPases that canonically utilize a conserved aspartate 
or glutamate to achieve guanine specificity at the 1 and 2 positions, as seen in Ras and 
Giα1 (Scheffzek, et al., 1997; Tesmer, et al., 1997).  
Interestingly, the conserved McrB signature sequence (NTAD, discussed in 
Chapter 1) does not associate with the guanine base. It is instead poised similarly to the 
conserved glutamine from switch II used to position the catalytic water, as seen in Ras-
RasGAP (Figure 5). Although the protein was crystallized in the presence of GDP-AlFx, 
AlFx, and thus the catalytic water, were not bound and could not be modeled. This is a 
direct consequence of the adjacent molecules bound to citrate exerting a conformational 
change to the GDP binding site, precluding GDP, AlFx, and water from binding (Figure 
6). This also resulted in a major, downward shift of the conserved Mg2+ binding residues 
S16 from Walker A and E88 and E89 from Walker B from the phosphates, also 
precluding Mg2+. Finally, catalytic residues normally positioned in trans, including the 
arginine finger, were over 10 Å away from the active site and could not be identified. 
Although the crystal structure of LlaI.2 failed to provide a comprehensive view 
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of the GTP active site, it did provide evidence for several key observations. First, LlaI.2 
(and EcMcrB) are definitively hexameric. Second, LlaI.2 utilizes a unique GTP binding 
mode via -stacking and reading of the 6 position. Third, the conserved NTAD signature 
sequence appears to be involved in positioning of the catalytic water, not for guanine 
specificity as previously described (Pieper et al., 1997 and 1999). Despite these findings, 
further investigation is warranted to fully elucidate the mechanisms of GTP binding and 
hydrolysis by McrB homologs. 
 
EXPERIMENTAL PROCEDURES 
Cloning, expression and purification of LlaI.2 
DNA encoding the Lactococcus lactis LlaI.2 protein was codon optimized for E. coli 
expression and synthesized commercially from Integrated DNA Technologies (IDT), 
Inc. DNA encoding the full-length LlaI.2 (residues 1-336) was amplified by PCR and 
cloned into pET21b, introducing a 6xHis tag at the C-terminus. Native LlaI.2 was 
transformed into BL21(DE3) cells, grown at 37°C in Terrific Broth to an OD600 of 1.0, 
and then induced with 0.3 mM IPTG overnight at 19°C. SeMet LlaI.2 was expressed in 
minimal media using methionine auxotrophs (T7 Express Crystal Competent E. coli, 
New England Biolabs) according to manufacturer protocols. The cells were harvested 
and washed twice with a nickel load buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 30 
mM Imidazole, 5% glycerol (v/v), and 5 mM bME). Pellets were typically flash frozen 
in liquid nitrogen and stored at -80°C. Thawed pellets from 500 mL cultures were 
resuspended in 30 mL of a nickel load buffer supplemented with 10 mM PMSF, 5 mg 
DNase I (Roche), 5 mM MgCl2 and a complete protease inhibitor cocktail tablet 
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(Roche). Lysozyme was added to 1 mg/mL and the mixture was incubated for 15 
minutes with rocking at 4°C. Cells were disrupted by sonication and the lysate was 
cleared of debris by centrifugation at 13,000 rpm (19,685x g) for 30 minutes at 4°C. 
The supernatant was filtered, loaded onto a 5-ml HiTrap chelating column charged with 
NiSO4 and then washed with a nickel load buffer. LlaI.2 was eluted with an imidazole 
gradient from 30 mM to 1 M. Pooled fractions were concentrated on a 30 kDa Millipore 
centrifugal concentrator. The concentrated protein was further purified by size exclusion 
chromatography (SEC) using a Superdex 200 16/600 pg column. All proteins were 
exchanged into a final buffer of 20 mM HEPES pH 7.5, 2M NaCl, 5 mM MgCl2, and 1 
mM DTT (5 mM for SeMet labelled) during SEC and concentrated to 30-60 mg/ml. 
Concentrations of purified proteins were determined by SDS-PAGE with BSA 
standards. 
 
Crystallization, X-ray data collection and structure determination of LlaI.2 
LlaI.2 (12 – 20 mg/mL) were prepared with GDP-AlFX (2.5 mM GDP, 25 mM NaF and 
2.5 mM AlCl3). Both native and SeMet LlaI.2 were crystallized by sitting drop vapor 
diffusion in 0.2 M tri-ammonium citrate pH 6.0, 20% PEG 6000 with a drop size of 2 
L and reservoir volume of 65 L. Crystals typically appeared within 1-2 weeks at 20°C 
and were cryoprotected with Parabar 10312 from Hampton Research and frozen in 
liquid nitrogen. They were of the space group H3 with unit cell dimensions a = 177.75 
Å, b = 177.75 Å, c = 65.03 Å and  = 90.00°,  = 90.00°,  = 120.00°. Single-wavelength 
anomalous diffraction (SAD) data were collected remotely on the tunable NE-CAT 24-
ID-C beamline at the Advanced Photon Source at the selenium edge energy at 12.663 
 163 
keV (0.9791 Å) (Table 1). Data were integrated and scaled using XDS (Kabsch, 2010) 
and AIMLESS (Evans, 2006) via the NE-CAT RAPD pipeline. Heavy atom sites were 
located using SHELX (Sheldrick, 2008) and phasing, density modification, and initial 
model building was carried out using the Autobuild routines of the PHENIX package 
(Adams et al., 2010). Further model building and refinement was carried out manually 
in COOT (Emsley et al., 2010) and PHENIX (Adams et al., 2010) respectively. The 
final model was refined to 1.92Å resolution with Rwork/Rfree = 0.1830/0.2109 (Table 
1) and contained two molecules in the asymmetric unit. 
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Table 1. X-ray data collection and refinement statistics for LlaI.2 
Data collection 
     PDB code  
     X-ray Source NECAT 24-ID-C 
     Wavelength (Å) 0.9791 
     Space group H3 
     Unit cell a = 177.75, b = 177.75, c = 65.03 Å 
 = 90.00°,  = 90.00°,  = 120.00° 
     Resolution, Åa 88.87 – 1.92 (2.07 – 1.92) 
     No. measured reflectionsa 1073325 (153257) 
     No. unique reflectionsa 84745 (24061) 
     Completeness (%)a 99.1 (100.0) 
     Multiplicitya 12.7 (6.36) 
     Rmerge
a 0.058 (0.521) 
     Mean I/σIa 21.8 (3.79) 
     CC1/2
a 1.000 (90.8) 
Refinement 
     Rwork/Rfree 0.1830 / 0.2109 
     RMSD  
          Bond lengths (Å) 0.007 
          Bond angles (°) 0.911 
     Ramachandran plot  
          Favored (%) 96.32 
          Allowed (%) 2.76 
          Outliers (%) 0.92 
     Average B-Factor 41.23 
     Clashscore 4.73 
     No. Atoms  
          Macromolecule 5284 
          Solvent 367 
          Total 5651 
a Parentheses indicate values for highest resolution shell 
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Figure 1. Crystallization and Data Collection of LlaI.2 + GDP-AlFx. Left. Crystals of LlaI.2 + GDP-
AlFx. Right. Diffraction data of LlaI.2 + GDP-AlFx crystals collected at the NE-CAT 24-ID-C beamline 
at the Advanced Photon Source.  
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Figure 2. Surface representation of LlaI.2 + GDP-AlFx. The structure of LlaI.2 + GDP-AlFx adopts a 
hexamer and is shown in three orientations. Each subunit within the hexamer is colored differently. 
Every odd molecule is bound to GDP while every even molecule is bound to citrate. 
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Figure 3. GDP binding site and conserved NxxD motif in LlaI.2. Zoomed in view of the GDP 
binding site in LlaI.2. The bound guanine base is stabilized via -stacking with F235 and R17 while 
Q174 reads the carbonyl at the 6 position. The Walker A proline (P217), lysine (K15), and serine (S16) 
and the Walker B acidic residues (E88 and E89) are also shown in sticks and colored grey. The 
conserved McrB NxxD motif is shown in sticks and colored green (N147 and D150). 
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Figure 4. Sequence alignment of McrB Walker A motifs. The blue arrow denotes a conserved 
aromatic residue in the residue immediately succeeding the P-loop that is responsible for -stacking 
with the guanine base. 
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Figure 5. Structural superposition of LlaI.2 + GDP-AlFx with Ras-RasGAP. Structural 
superposition of LlaI.2 with Ras-RasGAP reveals structural similarity between the two GTPase active 
sites. Notably the Q61 from the switch II motif of Ras-RasGAP is positioned similarly as N147 from 
the NxxD of LlaI.2 and suggests it may be involved in positioning the catalytic water. 
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 Figure 6. Structural comparison of LlaI.2 molecules bound with GDP or Citrate. Left. Zoomed in 
view of the LlaI.2 GTPase active site bound to GDP (green). Right. Zoomed in view of the LlaI.2 
GTPase active site bound to citrate (pink). Citrate acts as a pyrophosphate mimetic and closes the active 
site and precludes GDP from every even molecule within the hexamer. 
 
 
 
 
